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CHAPTER 1 
INTRODUCTION 
1.1. GENERAL 
Skeletal muscle is the largest tissue-mass of the human body. Surprisingly, it 
has achieved little attention from biochemists working in the field of inter-
mediary metabolism. As a result, our knowledge concerning the metabolism of 
mitochondria from skeletal muscle is rather limited when compared to that of 
mitochondria of other organs such as heart and, especially, liver. The study 
of the metabolism of skeletal muscle mitochondria is also of importance due to 
the fact that a disorder in metabolism of skeletal muscle mitochondria may be 
one of the causes responsible for a muscle disease. 
In the last decennia a number of patients has been described that suffered 
from skeletal muscle diseases which were attended with abnormalities of muscle 
mitochondria. These abnormalities, found by electron microscopical examination 
of muscle biopsy specimens, consisted of an increase in the number of mito-
chondria, an abnormal ultrastructure or both. Because of the occurrence of 
these mitochondrial abnormalities these muscle diseases are called "mitochon-
drial myopathies". In some cases, a biochemical defect in the mitochondria 
could be established. 
At present, a number of methods is available to find out whether a patient 
possibly suffers from a myopathy in which the mitochondria are etiologically 
involved. Clinical investigations must be suggestive for the occurrence of a 
myopathy. Clinical chemical investigations performed at rest and during 
exercise may indicate a disturbance in the energy metabolism of skeletal 
muscle. Histochemical and electron microscopical investigations of a muscle 
biopsy specimen give additional information with regard to the existence of a 
mitochondrial myopathy. 
If the results obtained with these investigations point to the existence of a 
mitochondrial myopathy, biochemical investigations are needed for the 
establishment and characterization of the disturbance in mitochondrial meta-
bolism. In Chapter 2 a literature survey will be presented in which all the 
sofar reported biochemical defects are discussed which were found in mitochon-
dria from patients suffering from a mitochondrial myopathy. 
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1.2. ENERGY METABOLISM OF SKELETAL MUSCLE 
Mitochondria are the cell organelles which catalyze the oxidative catabolism 
of substrates to CO2 and FLO coupled to the synthesis of energy. The main 
substrates for skeletal muscle mitochondria are fatty acids and pyruvate (1). 
In the resting and submaximally working muscle oxidation of fatty acids and 
ketone bodies is the main source of energy supply (2,3). During strenuous 
exercise glycolysis is accelerated which results in an increased lactate pro-
duction (4). Concomíttantly there is an increase in blood lactate concentra-
tion, this increase being dependent on the degree of exercise performed and on 
the extend of training of the subject performing the exercise (5-8). Lactate 
does not represent the endproduct of skeletal muscle carbohydrate metabolism. 
Both resting and exercising muscle contribute significantly to the removal of 
lactate from the bloodstream (9-16), in addition to other organs such as the 
liver (17), heart (18) and kidney (19). A considerable part of the lactate is 
oxidized by skeletal muscle to C0? (9). Lactate can only be oxidized to C0„ by 
the mitochondria after its conversion to pyruvate. So, oxidation of pyruvate 
by skeletal muscle mitochondria is, in addition to fatty acid oxidation, an 
important pathway generating energy necessary for normal functioning of 
skeletal muscle. 
1.3. SCOPE OF THIS INVESTIGATION 
The investigations described in this thesis were aimed to develop methods to 
study the metabolism of muscle mitochondria isolated from small human muscle 
biopsy specimens. With the aid of these methods it may also become possible to 
detect and characterize defects in mitochondrial metabolism at the molecular 
level in biopsy specimens from patients suffering from a myopathy which is 
supposed to be from mitochondrial origin. 
Since it was not always possible to obtain normal human skeletal muscle in 
quantities sufficient for biochemical studies, a lot of the experimental work 
was carried out on rat skeletal muscle. The procedures develooed were sub-
sequently applied to human skeletal muscle. 
Our study of mitochondrial metabolism has been limited to the oxidation of 
pyruvate and citric acid cycle intermediates. The first step in the metabolism 
of pyruvate is its oxidation to acetylCoA and C0? which is catalyzed by the 
pyruvate dehydrogenase complex. Pyruvate oxidation was studied by measuring 
the rate of CCL production fromll- dpyruvate. Optimal conditions for 
measuring pyruvate oxidation were established (Chapter 3). 
AcetylCoA formed by the action of the pyruvate dehydrogenase complex is 
further oxidized through the citric acid cycle. Fluxes through various seg­
ments of the citric acid cycle have been measured during pyruvate oxidation. 
The results are reported in Chapter 4. 
Pyruvate can be formed in the cytosol of the muscle cell from lactate taken up 
from the bloodstream or derived from glucose during glycolysis. In both cases 
pyruvate and NADH are produced in a 1:1 stoichiometry. Since the inner mito­
chondrial membrane is impermeable to NADH (20), reoxidation of cytosolic NADH 
must take place through means of transport shuttles for reducing equivalents. 
The most important shuttles, the malate-aspartate and o-glycerophosphate 
shuttles, have been reconstituted and the capacity of these reconstituted 
shuttle systems for the transport of reducing equivalents and their mutual 
interaction were studied (Chapter 5). 
Oxidation of intra-mitochondnally generated NADH is catalyzed by the mito­
chondrial respiratory chain. A method for the determination of the cytochrome 
content in mitochondria isolated from fresh and frozen-stored human muscle 
biopsy specimens is presented in Chapter 6. 
In Chapter 7 the results are reported of the effect of different isolation 
media on the biochemical and morphological characteristics of mitochondria 
isolated from rat skeletal muscle. Special attention was focussed on the rela­
tion between the rate of pyruvate oxidation and the content of cytochrome с 
present in the mitochondria after isolation. 
A discussion concerning the usefulness of muscle homogenates and isolated 
muscle mitochondria for the detection of a possible metabolic disturbance with 
the aid of the methods described in the foregoing chapters is presented in 
Chapter 8. 
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CHAPTER 2 
MITOCHONDRIAL MYOPATHIES 
2.1. INTRODUCTION 
The concept of mitochondrial myopathy was introduced by Luft and co-workers 
(1,2). They described a patient whose mam clinical symptoms were muscle weak­
ness and hypermetabolism from non-thyroid origin. The skeletal muscle mito­
chondria of this patient had ultrastructural abnormalities (giant mitochondria 
with densily packed cristae) and a biochemical defect (loose-coupling) could 
be demonstrated. The term mitochondrial myopathy has mainly been used to des­
cribe those myopathies in which ultrastructural abnormalities of muscle mito­
chondria were found, sometimes associated with accumulation of lipid or glyco­
gen in the muscle cell, but without an identified biochemical defect. 
A clear definition of mitochondrial myopathy is lacking. Such a definition can 
be based on the function of skeletal muscle mitochondria: the oxidative cata-
bolism of substrates coupled to the synthesis of energy. Therefore, we con­
sider a mitochondrial myopathy as a condition which is caused by a disturbance 
in metabolism of skeletal muscle mitochondria Information concerning mito­
chondrial metabolism can only be obtained by biochemical techniques This 
definition therefore implies that a mitochondrial myopathy can only be 
established by biochemical investigations. The morphological appearance of a 
diseased muscle cell may be suggestive for a disturbance in metabolism but it 
cannot be used as a criterion to establisch a mitochondrial myopathy Moreover, 
mitochondrial morphology may alter in a number of neuromuscular diseases in 
which there is no detectable evidence for a disturbance in mitochondrial meta­
bolism (3). 
This chapter is a survey of the literature concerning those cases in which a 
disturbance in metabolism of skeletal muscle mitochondria has been established. 
The mitochondrial myopathies are subdivided according to the reported bio­
chemical defect. At first, defects in pyruvate dehydrogenase complex and the 
citric acid cycle will be discussed. Thereafter, brief attention will be paid 
to those mitochondrial myopathies which are characterized by a defect in fatty 
acid oxidation. Finally, disturbances in the respiratory chain will be dis­
cussed. 
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2.2. THE PYRUVATE DEHYDROGENASE COMPLEX 
Oxidation of pyruvate is catalyzed by the pyruvate dehydrogenase complex, a 
multienzyme complex which is conposed of three different enzymes: pyruvate de­
hydrogenase (E,), lipoate acetyl transferase (£„) and lipoamide dehydrogenase 
(E3). 
The activity of the enzyme complex is inhibited by the reaction products NADH 
and acetylCoA. In addition to product inhibition, the mammalian enzyme complex 
is subject to regulation by a phosphorylation-dephosphorylation system, which 
consists of a kinase and a phosphatase These two enzymes catalyze the inter-
conversion of the enzyme complex between the inactive phosphorylated form and 
the active dephosphorylated form. Both the kinase and the phosphatase require 
Mg ions for their activity, although in different concentrations. The phos­
phatase requires Ca ions in addition (4,5). The activity of the MgATP-
requiring kinase is inhibited by ADP and pyruvate (6,7). The portion of the 
pyruvate dehydrogenase complex which is in the active form is the resultant of 
the relative activities of the kinase and the phosphatase and hence will be 
subject to regulation by the mitochondrial energy level which is reflected by 
the ATP/ADP ratio (8-13). In addition to the ATP/ADP ratio, the interconver-
sion between the active and the inactive form of the pyruvate dehydrogenase 
complex is also regulated by the NADH/NAD ratio and the acetylCoa/CoA ratio 
(14-17). More detailed information concerning the regulation of the enzyme 
complex can be found elsewhere (18-21). 
Henning et al. (22) showed that 15 Ί of the pyruvate dehydrogenase complex was 
in the active form in the gastrocnemius muscle of normal fed rats. This value 
decreased to 6 % during starvation. Electrical stimulation and mechanical work 
increased the percentage of the complex in the active form to 60. Studies with 
perfused rat skeletal muscle showed a decrease in pyruvate dehydrogenase 
activity during starvation and during streptozotocin induced diabetes (23,24). 
The activity of the enzyme increased during electrical stimulation of the 
perfused muscle. The changes in the percentage of the en ie complex which was 
in the active form paralleled the changes in the rate of pyruvate oxidation, 
suggesting that the interconversion of the enzyme complex between the active 
and inactive form is important for the regulation of the rate of pyruvate 
oxidation in vivo. 
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2.3. DISTURBANCES IN PYRUVATE DEHYDROGENASE COMPLEX AND CITRIC ACID CYCLE 
Only few patients have been described suffering from a defect in the pyruvate 
dehydrogenase complex in skeletal muscle. Blass and coworkers (25,26) des­
cribed a 9-year-old boy who suffered from intermittent ataxia and who had 
elevated blood levels of alanine and pyruvate but a normal level of lactate. 
Alanine excretion in urine was also elevated. Morphological investigations 
showed an increase of lipid droplets within the muscle fibers. Studies with 
white blood cells and fibroblasts of this patient showed that the rate of 
C0 9 production from [U- С1 glutamate, [1- Clacetate and II- Clpalmitate 
14 
was similar to that found in controls whereas [1- Clpyruvate oxidation was 
severely impaired. In further experiments with sonicated fibroblasts of the 
14 ι patient [1- CJpyruvate oxidation was measured with ferricyanide as electron 
acceptor. In this manner only pyruvate dehydrogenase activity (E,) is measured 
(27). This activity was less than 20 t of that found in controls. It was 
therefore concluded that this patient suffered from a deficiency of the first 
enzyme of the pyruvate dehydrogenase complex: pyruvate dehydrogenase (E,). 
Evidence for the involvement of skeletal muscle in the deficiency was obtained 
14 ι by the finding that [1- Clpyruvate oxidation in the patient's muscle homo-
genate, measured with ferricyanide as electron acceptor, was only 30 % of that 
found with controls. 
Kark et al. (28) investigated pyruvate oxidation in skeletal muscles from a 
group of 49 patients suffering from a variety of neuromuscular diseases. 
Pyruvate oxidation was measured in slices of skeletal muscle by determining 
the rate of C0 9 production from [2- Clpyruvate and was compared with the 
14 
rate of [1,4- Clsuccinate oxidation. In 15 out of these 49 patients the rate 
of pyruvate oxidation was lower than that in controls, whereas the oxidation 
rate.of succinate was normal in 12 out of these 15 patients. The patients 
having a low pyruvate oxidation rate suffered from a spinocerebellar degenera­
tion or a disease of the motor neuron. Metabolism of cultured fibroblasts was 
studied in only 3 of the patients, suffering from Friedreich's ataxia. Low 
rates of CO, production from [2- Clpyruvate but normal rates of [1- Cl 
14 palmitate and [U- Clglutamate oxidation were measured. In 3 other patients 
suffering from Friedreich's ataxia normal rates of pyruvate oxidation were 
found in skeletal muscle, which indicates that impaired pyruvate oxidation is 
not an integral feature of Friedreich's ataxia. It was reported in a subse­
quent paper (29), dealing with 5 patients suffering from Friedreich's ataxia, 
17 
that the activities of both the pyruvate dehydrogenase complex as well as the 
2-oxoglutarate dehydrogenase complex were decreased in sonicated fibroblasts. 
This means that not only pyruvate dehydrogenase but also citric acid cycle 
activity is impaired in these patients. It was suggested that the underlying 
mechanism responsible for the low rates of CCL production from ll- СІ 
14 
pyruvate and tl- C]2-oxoglutarate was a modification in lipoamide dehydro­
genase (E,), an enzyme common to both complexes. 
Recently, Robinson et al. (30) reported a deficiency of lipoamide dehydro­
genase. A male baby was described who suffered from a persistent metabolic 
acidosis with increased blood levels of lactate, pyruvate, 2-oxoglutarate and 
branched chain amino acids. Therapeutic trials with thiamine and a high fat 
diet were unsuccessful. The child died at the age of 7 months. Investigation 
of skeletal muscle, liver, heart, kidney and brain tissue revealed an activity 
of the pyruvate dehydrogenase complex which was reduced to 10-20 % of normal 
activity. Pyruvate dehydrogenase (E,) activity was normal, but lipoamide 
dehydrogenase (E.,) activity was deficient. Also, the 2-oxogl utarate dehydro­
genase complex was deficient in all tissues tested. 
The patients mentioned sofar suffered from a deficiency of one of the enzymes 
of the pyruvate dehydrogenase complex, in some cases associated with a defi­
ciency of the 2-oxoglutarate dehydrogenase complex. A deficiency in the 
phosphorylation-dephosphorylation system which regulates pyruvate dehydro­
genase activity has also been reported. 
Robinson and Sherwood (31) described a patient with a congenital lactic 
acidosis with high blood levels of lactate, pyruvate and free fatty acids. The 
patient died at the age of б months. An older sister succumbed at the age of 6 
weeks with a metabolic acidosis present from birth. Post-mortem studies were 
carried out on liver, skeletal muscle and brain tissue. A defect in gluconeo-
genesis could be ruled out. In addition, in all three tissues tested pyruvate 
dehydrogenase activity was normal and could be inactivated by preincubation 
2+ 2+ 
with ATP. However, reactivation by Ca and Mg was minimal in the patient's 
skeletal muscle and liver tissue; the estimated activity of the pyruvate 
dehydrogenase phosphatase being lower than 10 %. It was suggested that the 
deficiency of the pyruvate dehydrogenase phosphatase in liver and muscle and 
the normal activity of the kinase would maintain the pyruvate dehydrogenase 
complex in the inactive form in vivo, thus causing the lactic acidosis 
In summary, defects in the pyruvate dehydrogenase complex have been reported 
which are due to a deficiency of the E, or E, component of the complex or to a 
18 
deficiency of the pyruvate dehydrogenase phosphatase. To our knowledge, no 
deficiencies of the E- component or of the pyruvate dehydrogenase kinase have 
been reported up to now. A deficiency of E, results in a deficient activity of 
the 2-oxoglutarate dehydrogenase complex. Besides this latter deficiency, no 
other defects in functioning of the citric acid cycle have been reported in 
human muscle. 
2.4. DISTURBANCES IN FATTY ACID OXIDATION 
The myopathies in which a defect in fatty acid oxidation could be established 
were due either to a deficiency of carnitine (32-38) or to a deficiency of 
carnitine palmityltransferase. 
Carnitine deficiency results in "vacuolization" of muscle fibres due to 
accumulation of lipid. The carnitine content of skeletal muscle is lowered, 
whereas blood levels of carnitine are decreased or normal (39). In some cases 
the carnitine deficiency has also been found in heart (37) and liver (38). 
Carnitine palmityltransferase deficiency is associated with no or only a 
moderate accumulation of lipids in skeletal muscle fibres. In all the cases of 
carnitine palmityltransferase deficiency reported sofar recurrent episodes of 
myoglobinuria were observed (40-45). These latter are not noticed in carnitine 
deficiency. 
2 5. THE RESPIRATORY CHAIN 
Reducing equivalents generated by the pyruvate dehydrogenase complex, by fatty 
acid oxidation and by the reactions of the citric acid cycle are oxidized by a 
multienzyme system often referred to as the respiratory chain. The reactions 
of the respiratory chain take place in the mitochondrial inner membrane. The 
pathway of electron transport is schematically outlined in Fig 2.1. NADH is 
oxidized by a flavoprotein which subsequently transfers its electrons to 
coenzyme Q. In addition to flavoprotems, non-heme iron proteins are involved 
in electron transport in this region of the respiratory chain. In the span 
between coenzyme Q and oxygen electron transport is catalyzed by a class of 
heme-contaimng proteins called cytochromes Electrons derived from the flavo­
protein mediated oxidation of succinate, α-glycerophosphate and acylCoA enter 
the respiratory chain at the level of coenzyme Q. 
Transport of electrons is coupled to the synthesis of energy, which can be 
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Fig. 2.1. Scheme of the respiratory chain, including the site of action of 
some inhibitors. Fp: flavoprotein, NHI: non-heme iron, ETF: electron trans-
fering flavoprotein, Q: coenzyme Q, cyt.: cytochrome, TMPD: Ν,Ν,Ν',Ν'-tetra-
methy 1 -p-pheny 1 enedi ami ne. 
used for ATP synthesis or calcium uptake. Oxidation of one molecule of intra­
mitochondrial NADH yields three molecules of ATP which are thought to be 
synthesized at the three phosphorylation sites shown in Fig. 2.1. 
Oxidation of the flavoproteins which are reduced during succinate, a-glycero-
phosphate and acylCoA oxidation yields two molecules of ATP. The efficiency of 
the phosphorylation process is expressed as the P/0 ratio, which is the ratio 
between the number of ATP molecules formed and the number of oxygen atoms 
consumed. It will thus be clear that oxidation of pyruvate which yields NADH 
results in a P/0 ratio of three, whereas succinate oxidation leads to a P/0 
ratio of two. 
The oxidation of substrates is coupled to the synthesis of ATP in such a 
manner that the rate of respiration is controlled by the availability of ADP. 
This mechanism is called respiratory control. The coupling between oxidation 
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and phosphorylation is quantified by the respiratory control index, abbre­
viated RCI. The RCI is defined as the ratio between the rate of oxygen 
consumption by mitochondria incubated in state 3 and in state 4 conditions. 
State 3 refers to the situation where mitochondria are incubated in the 
presence of substrate, phosphate and ADP whereas state 4 represents the 
situation after the ADP has been phosphorylated to ATP (46). 
Proper mitochondrial functioning is dependent both on the presence of all 
those constituents catalyzing electron transport and ATP synthesis as well as 
on the regulatory mechanism which controls the coupling between oxidation and 
phosphorylation. Therefore, the following survey of mtochondnal myopathies 
which are accompanied by a defect in the respiratory chain has been separated 
into myopathies characterized by a deficiency of one of the components of the 
respiratory chain and myopathies characterized by a defect in regulation of 
oxidative phosphorylation. 
2.6. DEFICIENCIES IN THE RESPIRATORY CHAIN 
Goldfischer et al (47) described a patient suffering from the cerebro-hepato-
renal syndrome of Zellweger. Studies with isolated brain mitochondria of this 
patient indicated an impaired rate of oxidation of both NADH and flavoprotem 
linked substrates. Oxygen consumption with ascorbate plus TMPD was comparable 
to that observed with brain mitochondria from a control subject. With the 
latter substrate, electrons enter the respiratory chain at the level of cyto­
chrome с and hence a defect in the respiratory chain proximal to cytochrome с 
was suggested. Since the Zellweger syndrome is a disease in which also muscu­
lar abnormalities are noticed, it may be assumed that the defect is also 
present in skeletal muscle mitochondria. Evidence for the latter as well as 
information with regard to the localization of the deficiency was obtained 
from histochemical investigations. Succinate tetrazolium reductase activity 
with menadion as intermediate electron acceptor was extremely low in skeletal 
muscle, brain and liver tissue but staining was comparable with controls when 
phenazine metosulphate was used instead of menadion. Since menadion is thought 
to accept electrons from coenzyme Q whereas phenazine metosulphate accepts 
electrons from the succinate dehydrogenase flavoprotem, the deficiency in the 
respiratory chain was thought to be at the level of the non-heme iron pro­
teins 
Mackler et al. (48) studied pyruvate and succinate oxidation in mitochondria 
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isolated from skeletal muscle biopsy specimens from patients suffering from 
achondroplasia and in those from healthy controls. Succinate oxidation was 
comparable, but pyruvate oxidation proceeded with a P/0 ratio of 2 6 in 
controls and 2.1 in the patients mitorhondna. The authors therefore suggested 
a defect in ATP formation at the first phosphorylation site. 
Spiro et al. (49) described a hereditary disease of the nervous system and 
skeletal muscle with progressive ataxia, muscle weakness, reflex anomalies and 
insidious dementia. The patients were a 46 year old man and his 16 year-old 
son. Laboratory findings repeatedly indicated increased blood levels of 
creatine kinase. No ultrastructural abnormalities were present in the skeletal 
muscle mitochondria. Biochemical studies with isolated skeletal muscle mito­
chondria from the latter patient revealed low RCI and P/0 values with gluta­
mate plus malate as substrates The rate of oxygen consumption was 80 % lower 
in the patients mitochondria as compared with controls, both with glutamate 
plus malate and succinate as substrates. Furthermore, succinate oxidation was 
highly insensitive to inhibition by antimycin A. 
Difference spectra of mitochondria after reduction with succinate plus anti­
mycin A did not show a cytochrome b peak which, according to the authors, 
illustrated the insensitivity of the mitochondria towards antimycin A. 
Dithiomte reduction showed a spectrum with a blue shift of the α-band of 
cytochrome аа-э from 609 nm to 592 nm and an extraordinary large absorbtion 
peak at 432 nm which was ascribed to some kind of "b chromophore" or "an ab­
normal cytochrome oxidase complex". An alternative and less speculative 
explanation might be that the mitochondrial suspension was contaminated with 
hemoglobin and/or myoglobin which, after reduction with dithiomte, results in 
similar spectra (Chapter 6) This may also explain the absence of a spectrum 
after reduction with succinate plus antimycin A, a combination which is not 
able to reduce hemoglobin and myoglobin Therefore, the conclusion of the 
authors that these patients suffered from a cytochrome b deficiency is very 
speculative. 
A second patient suffering from a cytochrome b deficiency was reported by 
Morgan-Hughes et al. (50). The patient was a 38 year-old man suffering from 
extreme muscle fatiguabi11ty and weakness A muscle biopsy specimen revealed 
large subsarcolemmal accumulation of bizarre looking mitochondria. Mitochon­
drial respiration was decreased with different substrates Measurement of 
cytochromes revealed a decreased content of cytochrome b. 
A number of patients has been reported that suffered from a deficiency of 
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cytochrome аа^ τη skeletal muscle. Monnens et al. (51) desenbed a patient 
suffering from chronic lactic acidemia, growth faillure and nerve deafness 
Cytochrome oxidase activity was deficient in muscle tissue. Willems et al. 
(52) described a girl who suffered from Leigh's encephalomyelopathy. This 
patient had high blood levels of lactate and pyruvate and an increased lac­
tate/pyruvate ratio. A cytochrome oxidase deficiency could be established in 
skeletal muscle, the levels of cytochrome b and с were normal. Cytochrome 
oxidase activity was also reduced in heart muscle but was normal in liver. 
Skeletal muscle mitochondria varied greatly in size. In large mitochondria 
irregularly arranged cristae and fine granular electron-dense material were 
observed. No paracrystalline inclusions were present. The observed high levels 
of lactate and pyruvate and the increased lactate/pyruvate ratio in cerebro­
spinal fluid suggested a similar defect in brain 
Cytochrome oxidase deficiency has also been reported in trichopollodystrophy 
(53). In this case, cytochrome oxidase deficiency was present in muscle, brain 
and liver tissue and was most probably due to copper deficiency (54). 
Van Biervliet et al. (55) reported a patient suffering from a hereditary mito­
chondrial myopathy with lactic acidosis and a DeTom-Fanconi-Debré syndrome. 
The patient died at the age of thirteen weeks because of respiratory in-
sufficiency. A deficiency of both cytochromes aa, and b was established in 
skeletal muscle Twin sisters of this patient, exhibiting the same clinical 
symptoms, had died at the age of eleven weeks, without biochemical investiga-
tions being performed. So far, this patient is the only one reported to suffer 
from a deficiency of two cytochromes. 
A patient suffering from a defect in the enzyme system catalyzing ATP syn-
thesis from respiratory chain derived energy was reported by Schotland et al. 
(56). This patient was a 37 year-old woman suffering from non-progressive 
weakness present since early childhood. Electron microscopical examination of 
a skeletal muscle biopsy specimen disclosed numerous mitochondria containing 
crystalline inclusions. Respiratory rate as well as respiratory control were 
decreased in isolated mitochondria, but P/0 ratio was normal. Addition of 
uncoupler restored oxidation rates to normal values. Since calcium accumu-
lation kinetics were normal, indicating that energy could be generated in 
normal amounts by the respiratory chain, a defective ATPase activity was 
suspected and confirmed by comparing the latter with ATPase activity found in 
normal skeletal muscle mitochondria. 
In summary, a number of deficiencies in the respiratory chain have been 
23 
reported. Defects in the region proximal to the cytochromes are rather 
obscure, which may be caused by the absence of simple analytical procedures 
for measuring these components of the respiratory chain. Deficiencies of cyto-
chrome aa, and cytochrome b as well as a deficiency of ATPase have been 
established. 
2.7. LOOSE-COUPLING 
Luft and coworkers (1,2) described a 35 year-old woman suffering from severe 
hypermetabolism (basal metabolic rate approximately + 200 %) of non-thyroid 
origin and muscular wasting and weakness. The symptoms of hypermetabolism had 
been present since childhood. Biochemical studies with isolated skeletal 
muscle mitochondria from this patient revealed a number of abnormalities, the 
most important one being that the rate of respiration of the mitochondria was 
not controlled by the availability of ADP. The high rate of respiration 
measured in the absence of ADP could hardly be inhibited by oligomycin. 
However, addition of ADP to these mitochondria resulted in synthesis of ATP. 
So, respiratory control was absent but phosphorylation could be performed. 
These mitochondria were in a so-called state of loose-coupling. 
Tissue fractionation studies revealed that the amount of mitochondrial protein 
obtained per gram of muscle weight was three to four times greater than that 
obtained from skeletal muscle biopsy specimens from normal subjects. Morpho-
logical investigations showed an increase in the number of subsarcolemmal 
mitochondria, an extreme variety in mitochondrial size, an increased amount of 
densily packed mitochondrial cristae and numerous inclusions of various con-
figurations within the mitochondria. 
In subsequent studies with the same patient (57) an attempt was made to 
isolate the giant mitochondria, which could be seen by electronmicroscopy, by 
centrifugation of the patient's muscle homogenate at low centrifugational 
force (5000xg). One quarter of the total amount of mitochondrial protein 
present in the patient's muscle homogenate was isolated, whereas no mitochon-
drial pellet was obtained in this manner from muscle homogenates of normal 
subjects. Although the oxygen consumption per mg protein of the giant mito-
chondria was lower than that observed with the normal-sized mitochondria of 
the patient, essentially no differences were noticed with regard to respira-
tory control index and P/0 ratio since both mitochondrial fractions exhibited 
the phenomenon of loose-coupling. 
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Addition of the 14 OOOxg supernatant from a homogenate of the patient's muscle 
to mitochondria isolated from normal skeletal muscle did not influence the RCI 
of the latter. Therefore, the presence of an endogeneous factor being respons-
ible for loose-coupling was thought to be unlikely. 
Another patient, resembling very much the one described by Luft et al. (2), 
was described by Haydar et al. (58). It was a 19 year-old girl who also 
suffered from hypermetabolism, but myopathic symptoms were absent except for a 
very mild muscle weakness. Morphological examinations of skeletal muscle re-
vealed abnormalities comparable to those reported in Luffs patient: an in-
creased number of mitochondria, many with densily packed cristae and some 
containing paracrystalline inclusions. Isolated skeletal muscle mitochondria 
showed the phenomenon of loose-coupling and a high basal ATPase activity. 
Further investigations showed a normal rate of energy-dependent calcium up-
take, but the mitochondria were unable to retain accumulated calcium. The 
authors suggested therefore that recycling of calcium between the mitochondria 
and the cytosol might be responsible for a continuous stimulation of respira-
tion in vivo (59). However, since uptake of calcium proceeds at the expense of 
energy which would otherwise be used for ATP synthesis (60), recycling of 
calcium would be expected to result in uncoupling rather than loose-coupling. 
In addition to the two patients reported sofar, a number of patients has been 
described that also possessed loosely-coupled skeletal muscle mitochondria but 
that did not suffer from hypermetabolism (61-66). Clinical symptoms exhibited 
by these patients ranged from weakness of the pelvic musculature causing 
difficulties in walking (61) to such a muscle weakness that the patient was 
confined to a wheelchair (65). In one of the patients, described by Worsfold 
et al. (64), no clinical symptoms of a myopathy were mentioned. An increased 
blood level of creatine kinase was demonstrated in this patient, who was 
examined because of a family relationship with two other patients with 
clinical symptoms resembling facioscapulohumoral dystrophy, raised blood 
levels of creatine kinase and loosely-coupled skeletal muscle mitochondria. 
In summary, patients have been reported whose skeletal muscle mitochondria 
exhibited loose-coupling of oxidative phosphorylation. The myopathic symptoms 
in these patients ranged from mild muscle weakness to complete disability. In 
addition, severe hypermetabolism may be present. The most profound myopathic 
symptoms are found in patients who do not suffer from hypermetabolism. 
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2.8. DISCUSSION 
As stated in the introduction, the term mitochondrial myopathy was used in 
this survey to describe disturbances in metabolism of skeletal muscle mitochon-
dria. In a number of cases the expression of the disturbance was not limited 
to skeletal muscle but other tissues were also involved. These latter cases 
therefore seem to represent more generalized "mitochondriopathies". 
Since mitochondrial abnormalities may also be present in tissues other than 
skeletal muscle, the clinical symptoms presented by the patients are subject 
to great variation. Although all patients have symptoms in varying degree 
suggestive for a myopathy, there are no specific symptoms which indicate that 
the origin of the myopathy lies within the mitochondrion. The only exception 
seems to be hypermetabolism from non-thyroid origin, a symptom of which the 
relation to mitochondrial functioning is obvious. 
Two types of investigations may be performed to obtain information about the 
possible involvement of mitochondria in a myopathy. Measurement of the changes 
in blood levels of lactate, pyruvate, fatty acids and ketone bodies during 
exercise seems very usefull to detect disorders in skeletal muscle metabolism 
(50,67). The combination of histochemical and electron microscopical examina-
tion of a muscle biopsy specimen may indicate whether qualitative and/or 
quantitative changes are present in skeletal muscle mitochondria. 
Morphological criteria alone cannot be used to establish a mitochondrial myo-
pathy. The observed abberations in mitochondrial morphology are unspecific and 
consist mainly of increases in mitochondrial size and the presence of inclu-
sions within the mitochondria. Sometimes, mitochondrial morphology is abnormal 
without a detectable biochemical defect in mitochondrial function. This has 
been found for example in a patient suffering from the Kearns-Shy syndrome 
(68), in which mitochondrial morphology is frequently abnormal (68-71). It has 
been shown once that cytochrome oxidase activity was not present within the 
paracrystalline inclusions, suggesting that they do not have a functional role 
within the mitochondria (72). Paracrystalline inclusions and the formation of 
giant mitochondria can be induced by ischemia in rat soleus muscle (73), 
indicating that mitochondrial morphology may be disturbed by extra-mitochon-
drial factors (3). On the other hand, in the patient reported by DiMauro and 
DiMauro (40) who suffered from carnitine palmityltransferase deficiency, no 
ultrastructural abnormalities of skeletal muscle mitochondria were detected. 
The biochemical defect present in the mitochondrial myopathies is the absence 
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or decreased activity of one of the enzymes involved in oxidative catabolism 
of pyruvate and fatty acids. Two exceptions can be noticed. Firstly, deficien­
cy of carnitine and secondly the mitochondrial myopathies in which the skele­
tal muscle mitochondria exhibit loose-coupling. In the latter case, all 
enzymes seem present but coordination of activities necessary for optimal 
functioning of the process of oxidative phosphorylation is absent. 
Deficiencies in pyruvate metabolism were reported in the pyruvate dehydro­
genase complex and the respiratory chain, which may be regarded as the first 
and last part of pyruvate metabolism, respectively. Reports concerning 
deficiencies in the citric acid cycle, which may be regarded as the inter­
mediate part of pyruvate metabolism, are scarce and limited to defects in the 
2-oxoglutarate dehydrogenase complex (29,30). This may be related to the 
absence of adequate analytical procedures for measurement of citric acid cycle 
activity in skeletal muscle. 
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CHAPTER 3 
PYRUVATE OXIDATION IN RAT AND HUMAN SKELETAL MUSCLE MITOCHONDRIA 
3.1. INTRODUCTION 
A vast amount of knowledge has accumulated during the past years regarding 
pyruvate oxidation. Regulation of the isolated pyruvate dehydrogenase complex 
as well as regulation of pyruvate oxidation in intact mitochondria have been 
studied extensively (1-7). The majority of these studies has been performed 
with liver and heart muscle mitochondria. There have been hardly any studies 
concerning pyruvate oxidation in skeletal muscle mitochondria. The investiga-
tions performed so far are studies about isolation procedures and hence are 
only concerned with oxygen uptake and respiratory control (8-13). 
Pyruvate oxidation in mitochondria isolated from various tissues and species 
is known to be stimulated by citric acid cycle intermediates and carnitine (4, 
14-18). In this chapter the stimulatory effects of citric acid cycle inter-
mediates and carnitine on pyruvate oxidation in skeletal muscle mitochondria 
were studied in order to obtain information about the rate-limiting step 
during [1- C)pyruvate oxidation. The results obtained with rat skeletal 
muscle mitochondria are compared with those obtained with human skeletal 
muscle mitochondria. Application of the results for the diagnosis of a defect 
in human skeletal muscle pyruvate oxidation is discussed. 
3.2. MATERIALS AND METHODS 
Preparation of skeletal musale mitochondria. Rat skeletal muscle mitochondria 
were prepared from the hind leg muscles of male Wistar rats, weighing 150-200 
g and fasted overnight. Human skeletal muscle was obtained from patients with 
no known neuromuscular disease. The muscle specimens were placed in ice-cold 
isolation medium containing 250 mM sucrose, 2 mM EDTA, 10 mM Tris, 50 U 
heparin/ml, final pH 7.4 (SETH-medium). All further operations were carried 
out at 0-4 . Muscle tissue freed from fat and connective tissue, cut into very 
fine pieces with scissors and suspended in SETH-medium (lg/10ml). Homogeniza-
tion was performed by hand with a teflon-glass Potter-Elvehjem type homo-
genizer. The resulting homogenate was centrifuged for 10 min at 600 xg to 
remove nuclei and cell debris. After repeating this centrifugation, mitochon-
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dria were isolated from the resulting supernatant by centrifugation for 10 min 
at 14 000 xg. The mitochondrial pellet was rinsed with SET-medium (which is 
SETH-medium from which heparin is omitted) to remove the fluffy layer, re-
suspended in SET-medium and centrifuged again for 10 min at 14 000 xg. The 
mitochondria were finally taken up in SET-medium. Oxygen consumption of the 
mitochondria, measured as described by Max et al. (13), showed respiratory 
control indices higher than 4 and P/0 ratios between 2.8 and 3.0 with pyruvate 
and malate as substrates, indicating tight coupling between oxidation and 
phosphorylation. 
Incubations and assays. Mitochondria were incubated in small sealed glass 
vials at 37 in a shaking waterbath. The basic incubation medium contained in 
a final volume of 500 μΐ: 30 mM potassium phosphate, 2 mM EDTA, 10 mM Tris, 5 
mM MgCl2, 75 mM KCl, 25 mM sucrose, 20 mM glucose, 2 mM ADP and 1-2 U hexo-
kinase. The final pH was 7.4. Concentrations of substrates are given in the 
legends to Figures and Tables. Incubations were started by addition of 20-30 
jug mitochondrial protein. Small plastic tubes containing 200 μλ Hyamine were 
14 inserted into the vials in order to trap CO, produced during oxidation of 
[1- Clpyruvate (19). Incubations were terminated, after 10 or 15 min, by 
addition of 200 μΐ 3 M HCIO.. The vials were left for an additional 30 min in 
14 the shaking waterbath to ensure complete trapping of the C0 ? by the Hyamine. 
Thereafter, the small plastic tubes with the Hyamine were transferred into 20 
ml glass counting vials containing 10 ml toluene and 40 mg Omnifluor. Radio­
activity was measured in a Nuclear Chicago Mark I liquid scintillation 
counter. Under all conditions tested COj, production from (1- Clpyruvate was 
linear with respect to time and the amount of protein present. 
Pyruvate was determined enzymatically according to Czok (20). 
Protein was determined by the method of Lowry et al. (21) using bovine serum 
albumin as a standard. 
Statistical analyses were performed with the Student's t test. 
Chemicals. The sodium salt of [1- C] pyruvate was purchased from The Radio­
chemical Centre, Amersham, England and stored freeze-dried under nitrogen in 
sealed ampoules at -20 to minimize decomposition (22). Further reagents were 
purchased as follows: L(-) carnitine and hexokinase (freeze-dried, 40 U/mg) 
from Koch Light, Colnbrook, England; rotenone and ADP from Boehringer, 
Mannheim, W-Germany; Omnifluor from NEN Chemicals GmbH, Dreieichenhain, 
W-Germany and the hydroxide of Hyamine 10X from Packard Instrument Co., 
Chicago, 111. U.S.A. All other chemicals were of the purest grade cornmercially 
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available. 
3.3. RESULTS 
3.3.1. Stimulation of pyruvate oxidation by oitric acid ayote intermediates. 
The effect of increasing concentrations of malate, fumarate and succinate on 
the rate of pyruvate oxidation by rat skeletal muscle mitochondria is shown in 
Fig. 3.1. 
О 0 5 1 0 2 0 
cilnc acid cycle intermedíate ImMl 
Fig. 3.1. Stimulation of pyruvate oxidation by citric acid cycle inter-
mediates. Rat skeletal muscle mitochondria (54 дд protein/ml) were incubated 
in the basic incubation medium supplemented with 1 mM pyruvate (0.15 дСі 
[1- Clpyruvate). Malate, fumarate and succinate were present in a final 
concentration as shown in the figure. 
о -o malate, χ χ fumarate, · · succinate. 
All the citric acid cycle intermediates tested stimulate pyruvate oxidation 
although the effect of fumarate and succinate is smaller than that observed 
with malate. In all instances a final concentration of 1 mM of the added 
citric acid cycle intermediates is enough to approximate the maximal stimula­
tory effect which can be obtained with a particular intermediate. 
In the presence of malate the rate of pyruvate oxidation measured by the pro-
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duction of C0 ? from [1- Cl pyruvate equals the rate of pyruvate dis­
appearance from the incubation medium measured enzymatically, indicating that 
all the pyruvate taken up by the mitochondria is oxidized to COp (Table З.1.). 
TABLE 3.1. 
RATE OF PYRUVATE UPTAKE AND OXIDATION 
Rat skeletal muscle mitochondria were incubated in the basic incubation medium 
supplemented with 1 mM pyruvate (0.15 /JCÌ tl-^cl pyruvate) and 1 mM malate. 
Pyruvate uptake was measured as the difference in pyruvate concentration in 
the neutralized deproteinized perchloric acid extracts of the medium before 
and after incubation. Pyruvate oxidation was measured as described in Mate-
rials and Methods. 
Values shown are means + S.D., of the number of experiments given in the 
parentheses. 
Parameter Rate (дтоі/тд protei η.h) 
Pyruvate uptake 16.3 + 1.9 (4) 
Pyruvate oxidation 15.8 + 1.2 (6) 
3.3.2. Stimulation of pyruvate oxidation by oarnitine. 
The rate of CO« production from [1- Clpyruvate is not only increased by 
addition of citric acid cycle intermediates but also by addition of carnitine 
to the mitochondria. AcetylCoA formed by the pyruvate dehydrogenase complex 
can be transferred to carnitine by the action of carnitine acetyl transferase 
(23, 24) to form acetyl carni tine and to regenerate mitochondrial CoASH, there­
by relieving inhibition of the pyruvate dehydrogenase complex by acetylCoA 
(25). Carnitine acetyl transferase activity has been shown to be present in 
muscle mitochondria (26). The effect of carnitine on pyruvate oxidation can be 
seen in Fig. 3.2. The double reciprocal plot of oxidation rate versus carni­
tine concentration shows biphasic kinetics. Two apparent К values of 0.2 mM 
m 
and 3.7 mM can be calculated corresponding with a V of 4.1 /jmoles/mg 
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protein, h and 16.1 ^mol/mg protein, h, respectively. The ì / ^ reached at in-
ΓΠαΧ 
finite carnitine concentration approximates closely the oxidation rate ob­
tained in the presence of 1 mM malate which was 17.0 мтоі/тд protein.h in this 
experiment. 
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Fig. 3.2. Lineweaver-Burk plot for carnitine stimulation of pyruvate oxidation 
14 in rat skeletal muscle mitochondria. 1 mM Pyruvate (0.15 мСі 11- upyruvate) 
was added to the basic incubation medium. 
In the presence of malate no acetate formation was observed. The main products 
formed in the presence of carnitine were acetylcarnitine and acetate, the 
latter probably resulting from hydrolysis of acetylcarnitine. 
3.3.3. Pyruvate oxidation without addition of citric acid cycle intevmediabes 
or carnitine 
An attempt was made to investigate whether the low rate of pyruvate oxidation 
measured when no citric acid cycle intermediates or carnitine were added was 
due to pyruvate oxidation supported by endogenous citric acid cycle inter­
mediates or due to some non-specific decarboxylation of the [1- Clpyruvate. 
Therefore, the effect of arsenite, an inhibitor of the pyruvate dehydrogenase 
complex (27) was studied. Fig. 3.3. shows the effect of arsenite on pyruvate 
oxidation measured without additions, with carnitine and with malate. 
35 
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Fig. 3.3. Inhibition of pyruvate oxidation by arsenite. Rat skeletal muscle 
mitochondria (115 μς protein/ml) were incubated in the basic incubation medium 
14 
supplemented with 1 mM pyruvate (0.15 ¿<Сі [1- CJpyruvate). Further additions 
were: · · none, о о 5 mM carnitine, χ χ 1 mM malate. 
A prompt inhibition of pyruvate oxidation by low concentrations of arsenite is 
observed in the presence of malate or carnitine. However, hardly any inhibi­
tion is observed when pyruvate oxidation is measured without addition of 
citric acid cycle intermediate or carnitine. Moreover, the residual activity 
measured under all three conditions is the same. This indicates that part of 
the pyruvate oxidation measured is insensitive to arsenite inhibition and 
hence this activity may not represent pyruvate dehydrogenase activity. This is 
not supported by the effects observed with rotenone or malonate as shown in 
Table 3.2. The residual activity is completely destroyed by heating of the 
mitochondria (3 min at 100 ) prior to incubation. 
TABLE 3.2. 
EFFECT OF INHIBITORS ON PYRUVATE OXIDATION WITHOUT ADDITION OF CITRIC ACID 
CYCLE INTERMEDIATES OR CARNITINE 
Rat skeletal muscle mitochondria (46 ^g/ml) were incubated in the basic 
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incubation medium supplemented with 1 mM pyruvate (0.15 дСі [1- Clpyruvate). 
Incubations were terminated after 15 min. Inhibitor concentrations were 1 дд/ 
ml rotenone 5mM malonate, 0.2 mM arsenite. 
.,,... Pyruvate oxidation rate 
Addition — — •— 
(дтоі/тд protei η.h) 
None 1.5 
Rotenone 0.2 
Malonate 0.5 
Arsenite 1.1 
3.3.4. Pyruvate oxidation in rat and human skeletal musale mitochondria 
In Table 3.3. the stimulatory effects on pyruvate oxidation of the citric acid 
cycle intermediates malate, fumarate and succinate are compared with the 
effect of carnitine in rat and human skeletal muscle mitochondria. 
The values for the rate of pyruvate oxidation obtained with human skeletal 
muscle mitochondria are presented in two manners. Both the absolute values 
(цтоі/тд protein.h) and the relative values (expressed as percentage of those 
obtained with 1 mM malate) are presented. In the latter manner standard devia­
tions were greatly reduced. 
Both in rat and human skeletal muscle mitochondria maximal stimulation of 
pyruvate oxidation is achieved by malate although this effect is greater in 
rat than in human skeletal muscle mitochondria. A decrease in stimulatory 
effect in the order malate ) succinate) fumarate is observed both with rat 
and human muscle mitochondria. 
Addition of carnitine results in a stimulation of pyruvate oxidation rate 
which is in rat skeletal muscle mitochondria half of that observed with malate 
while in human skeletal muscle mitochondria the same stimulation is achieved 
as with malate. 
In skeletal muscle mitochondria of both species pyruvate oxidation measured in 
the presence of fumarate or succinate can be further stimulated by addition of 
carnitine. In the presence of malate no further stimulation by carnitine is 
observed. 
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TABLE 3.3. 
EFFECT OF CITRIC ACID CYCLE INTERMEDIATES AND CARNITINE ON THE RATE OF PYRUVATE OXIDATION IN RAT AND HUMAN 
SKELETAL MUSCLE MITOCHONDRIA 
Mitochondria were incubated in the basic incubation medium supplemented with 1 mM pyruvate (0.15 дСі [1- Cl 
pyruvate). Additions of citric acid cycle intermediates (1 mM) or carnitine (5 mM) were as indicated. 
Values shown are means + S.D., of the number of experiments given in the parentheses. 
The significance of the difference in oxidation rate in the presence and absence of carnitine was calculated. 
Addition Rat muscle Human muscle 
μπιοΐ/nig protein.h ^rnol/mg protei η.h relative (%) 
None 
Malate 
Fumarate 
Succinate 
Carnitine 
Carnitine + malate 
Carnitine + fumarate 
Carnitine + succinate 
1.1 + 0.2 (5) 
15.8 + 1.2 (6) 
7.5 + 1.1 (4) 
10.7 + 0.6 (4) 
8.3*+ 0.8 (5) 
16.4 + 1.7 (5) 
13 .0% 1.9 (4) 
14 .7% 1.4 (4) 
2.0 + 0.8 (5) 
7.5 + 3.5 (6) 
3.0 + 1.3 (4) 
4.9 + 2.0 (4) 
7 . 9 % 3.8 (6) 
8.8 + 4.3 (5) 
7.1 + 3.3 (4) 
7.3 + 3.8 (4) 
2 5 + 3 
100 
45 + 10 
7 3 + 5 
105% 9 
110 + 7 
106% 12 
107% 9 
p<0.05 
3.4. DISCUSSION 
Pyruvate oxidation in skeletal muscle mitochondria incubated under state 3 
conditions without addition of a citric acid cycle intermediate or carnitine 
is limited by the availability of oxaloacetate. This can be concluded from the 
stimulatory effect of citric acid cycle intermediates and carnitine. The 
differences which are observed between the stimulatory effects of malate, 
fumarate and succinate (Fig. 3.1.) are probably caused by differences in the 
permeability of the mitochondrial membrane towards these intermediates. 
The role of acceptor for acetylCoA generated by the action of the pyruvate 
dehydrogenase complex is not restricted to oxaloacetate but can also be full-
filled by carnitine (14, 16, 18, 23, 24). The biphasic kinetics of the stimu­
lation of pyruvate oxidation by carnitine shown in Fig. 3.2. points to the 
action of two different enzymes. The V
m = v / reached at infinite carnitine 
ΓΠαΧ 
concentration closely approximates the activity found in the presence of 
malate. So, both malate and carnitine are able to stimulate pyruvate oxidation 
to the same extent although the effect of malate is reached at far lower 
concentrations. 
Pyruvate oxidation measured without addition of citric acid cycle inter­
mediates or carnitine is supported by endogenous citric acid cycle inter­
mediates. This can be concluded from the observed inhibition by malonate 
(Table 3.2). Spontaneous decarboxylation cannot be responsible for this 
residual activity since the latter is inhibited by malonate, rotenone and 
heating of the mitochondria. The partial insensitivity towards arsenite was 
attributed in a recent report concerning kidney mitochondria (28) to an "over-
14 
estimation" of the amount of evolved CCL. However, since arsenite is a water 
soluble reagent and the pyruvate dehydrogenase complex is bound to the inner 
mitochondrial membrane, partial inaccessibility of the pyruvate dehydrogenase 
complex towards arsenite in intact mitochondria is an alternative explanation. 
Citric acid cycle intermediates and carnitine stimulate pyruvate oxidation 
both in rat and human skeletal muscle mitochondria. Large standard deviations 
were obtained with human skeletal muscle mitochondria when the activities are 
expressed on protein base (Table 3.3. ). This was reported previously (29). 
Therefore, the problem of finding a better reference base to express the 
activities found in human material needs further investigation. 
The stimulatory effect of carnitine on pyruvate oxidation in the presence of 
fumarate or succinate indicates that with these two citric acid cycle inter-
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mediates the availability of the acetylCoA acceptor, oxaloacetate, is still 
rate-limiting for maximal pyruvate dehydrogenase activity. Since no further 
stimulation of pyruvate oxidation can be achieved by carnitine in the presence 
of malate, the rate of acetylCoA production is the rate-limiting step during 
14 [1- upyruvate oxidation under this condition. The stimulation of pyruvate 
oxidation by carnitine is equal to that observed with malate in human skeletal 
muscle mitochondria in contrast to that in rat skeletal muscle mitochondria. 
This suggests that carnitine acetyl transferase activity is relatively low in 
rat skeletal muscle mitochondria. 
Parallel incubations of human skeletal muscle mitochondria with tl- Clpyru-
vate plus malate or carnitine will be the best means of obtaining information 
about the capacity of human skeletal muscle mitochondria to oxidize pyruvate. 
It not only permits the diagnosis of an impaired rate of pyruvate oxidation 
but it also discriminates between a defect in pyruvate dehydrogenase and an 
impaired capacity of the mitochondria to oxidize acetylCoA via the citric acid 
cycle. In case of a defect in the respiratory chain it can be expected that 
pyruvate oxidation will be impaired both with malate and with carnitine added. 
Then further investigations are indicated to determine whether the defect in 
pyruvate oxidation is due to a defect in pyruvate dehydrogenase or whether the 
defect is secundary to a defect in the respiratory chain. 
3.5. SUMMARY 
Pyruvate oxidation in rat and human skeletal muscle mitochondria was studied 
14 14 
by measuring the rate of C0? production from [1- upyruvate under state 3 
conditions. 
The rate of pyruvate oxidation is controlled by the availability of acetylCoA 
acceptor since addition of citric acid cycle intermediates or carnitine 
results in a stimulation of pyruvate oxidation. 
Pyruvate oxidation proceeds at its maximal rate in the presence of malate 
since no further stimulation is observed by addition of carnitine. It is 
concluded that pyruvate dehydrogenase is the rate-limiting step during pyru-
vate oxidation in the presence of malate. 
In human skeletal muscle mitochondria pyruvate oxidation proceeds maximally 
both in the presence of malate or carnitine. Parallel incubations of these 
mitochondria with [1- Clpyruvate plus malate and [1- Clpyruvate plus carni-
tine may allow to establish disturbances in pyruvate oxidation and to discri-
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minate between defects in the pyruvate dehydrogenase complex and in the acti­
vity of the citric acid cycle. 
3.6. REFERENCES 
1. Linn,T.C., Pettit.F.H. and Reed,L.J. (1969) Proc.Natl.Acad.Sci. U.S.A. 62, 
234-241. 
2. Wieland,0. and Siess.E. (1970) Proc.Natl.Acad.Sci. U.S.A. 65, 947-954, 
3. Hansford,R.G. (1976) J.Biol.Chem. 251, 5483-5489. 
4. La Noue,К.F., Nicklas,W.J. and Williamson,J.R. (1970) J.Biol.Chem. 245, 
102-111. 
5. Schuster,S.M. and Olson,M.S. (1972) J.Biol.Chem. 247, 5088-5094. 
6. La Noue,К.F., Bryla,J. and Williamson,J.R. (1972) J.Biol.Chem. 247, 667-
679. 
7. Stucki.J.W. and Walter,P. (1972) Eur.J.Biochem. 30, 60-72. 
8. Dow,D.S. (1967) Biochemistry 6, 2915-1922. 
9. Makinen,M.W. and Lee.C.P. (1968) Arch.Biochem.Biophys. 126, 75-82. 
10. Hulsman,W.С, De Jong,J.W. and Van Tol,A. (1968) Biochem.Biophys.Acta 162, 
292-293. 
11. Peter,J.B. (1968) Biochem.Med. 2, 179-189. 
12. Bullock,G., Carter,E.E. and White,A.M. (1970) FEBS lett. 8, 109-111. 
13. Max.S.R., Garbus.J. and Wehman.H.J. (1972) Anal.Biochem. 46, 576-584. 
14. Childress,C.C., Sacktor.B. and Traynor,D.R. (1966) J.Biol.Chem. 242, 754-
760. 
15. Von Korff,R.W. and Kerpel-Fronius,S. (1975) J.Neurochem. 25, 767-778. 
16. Hansford,R.G. and Johnson,R.N. (1976) Comp.Biochem.Physiol. 55 B, 543-551. 
17. Lysiak.W., Szutowicz,A. and Angielski.S. (1976) Acta Biochem.Polon. 23, 
325-333. 
18. Hutson.S.M., Van Dop,С and Lardy,H.A. (1977) J.Biol.Chem. 252, 1309-1315. 
19. Fox.R.M. (1971) Anal.Biochem. 41, 578-579. 
20. Czok.R. and Lamprecht,W. (1974) Methoden der enzymatischen Analyse 
(Bergmeyer.H.U. ed.) pp 1491-1496, Verlag Chemie, Weinheim. 
21. Lowry.O.H., Rosebrough.N.J., Farr.A.L. and Randall,R.J. (1951) J.Biol. 
Chem. 193, 265-275. 
22. Von Korff.R.W. (1964) Anal.Biochem. 8, 171-178. 
23. Pande,S.V. (1971) J.Biol.Chem. 246, 5384-5390. 
24. Pande,S.V. (1975) Proc.Natl.Acad.Sci. U.S.A. 72,883-887. 
41 
25. Wieland,0. and Von Jagow-Westermann.B. (1969) FEBS Lett. 3,271-274. 
26. Fritz,I.В. and Yue,K.T.N. (1964) Am.J.Physiol. 206, 531-535. 
27. Reiss.O.K. and Hellerman,L. (1958) J.Biol.Chem. 231, 557-569. 
28. Robinson,B.H., Oei.J., Dhadli,S.C. and Halperin.M.L. (1977) J.Biol.Chem. 
252, 5661-5665. 
29. Kark.R.A.P., Weinbank,E.С , Blass,J.P. and Engel.W.К. (1973) Clinical 
Studies in Myology (Kakulas.B.A. ed.), pp 98-107, Exp.Ned.Found., Amster­
dam. 
42 
CHAPTER 4 
CITRIC ACID CYCLE ACTIVITY IN RAT AND HUMAN SKELETAL MUSCLE MITOCHONDRIA 
4.1. INTRODUCTION 
AcetylCoA formed by the pyruvate dehydrogenase complex during pyruvate oxida-
tion is oxidized to CO2 by the reactions of the citric acid cycle. Although 
this is a cyclic process, considerable evidence has been obtained that there 
is no uniform flux through various segments of the cycle. Accumulation of 
citrate, 2-oxoglutarate and succinate has been reported during pyruvate oxida-
tion in isolated heart (1-4), brain (4-6) and liver (7) mitochondria. 
The aim of the experiments described in this chapter was to obtain information 
concerning citric acid cycle activity in skeletal muscle mitochondria. The 
method which seemed most suitable for obtaining this information is based on 
14 14 
the measurement of C0? production from C-labeled cycle intermediates. 
Interpretation of the results obtained requires knowledge about possible 
14 
accumulation of citric acid cycle intermediates, since CO« is only liberated 
in the isocitrate and 2-oxoglutarate dehydrogenase catalyzed reactions. 
Citric acid cycle activity during pyruvate plus malate oxidation was first 
studied in rat muscle mitochondria. Disappearence of substrates from the 
incubation medium and accumulation of intermediates were measured by enzymatic 
procedures. Citric acid cycle activity was also measured after reconstitution 
of the malate-aspartate shuttle to study the effect of the latter on the 
accumulation of cycle intermediates. Finally, activities of the various 
segments of the citric acid cycle were determined by measuring the rate of 
14 14 
CO« production from C-labeled intermediates. With the latter technique 
citric acid cycle activity was also determined in human skeletal muscle mito-
chondria. 
4.2. MATERIALS AND METHODS 
Isolation procedure for skeletal muscle mitochondria, composition of the basic 
14 incubation medium and assays of CO2 production and of protein are described 
in Chapter 3. All incubations were performed in state 3 conditions. The 
concentration of phosphate in the medium was 30 mM, which has been shown to 
result in an optimal rate of malate transport in rat heart mitochondria (8). 
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Metabolite assays. For the enzymatic determination of metabolites reactions 
were stopped by addition of 0.2 ml 6 M HC10« to I ml incubation medium. After 
centri fugati on to remove precipitated protein, the samples were neutralized 
with 4 M КОН. Assays of pyruvate, malate, 2-oxoglutarate and NAD were per­
formed according to standard enzymatic procedures (9) in the neutralized 
samples. The assay of succinate was based on the oxidation of succinate to 
fumarate by rat heart mitochondria (10) and coupled to the reduction of cyto­
chrome с The latter was measured spectrophotometrically at 550 nm. The 
cuvette contained in a final volume of 1 ml : lOmM Tris-HCl, 5 mM MgCl-. 2 mM 
KCN, 2 /ug rotenone and 90 μΜ cytochrome c, final pH 7.4. The reaction was 
started by addition of 20 μΐ of a suspension of rat heart mitochondria, which 
were isolated as described for skeletal muscle mitochondria. The mitochondria 
isolated from one heart were taken up in 1 ml SETH medium. The increase in 
absorbance at 550 nm was proportional to the amount of succinate. Assays were 
carried ou+ in the presence of added succinate as standard. 
High voltage electrophoresis. High voltage electrophoresis of neutralized 
samples was performed on strips (40 χ 4 cm) of Whatman 3 MM paper for 30 m m 
at 10 mA per strip in 2 M acetic acid adjusted to pH 3.0 with pyridine (11). 
After drying, the strips were cut in 1 cm pieces which were transferred to 
glass counting vials. The pieces were shaken vigorously with 5 ml of 0.1 M 
14 NaOH for 45 m m to extract C-labeled intermediates. Thereafter, 10 ml of 
Instagel were added and radioactivity was measured in a Nuclear Chicago Mark I 
liquid scintillation counter. 
Che'noals. 11- Clpyruvate, 12- CJpyruvate andtU- Clmalate were purchased 
from the Radiochemical Centre, Amersham, England, II- C]2-oxoglutarate from 
NEN Chemicals GmbH, Dreieichenhain, Germany. Cytochrome с (horse heart), 
glutamate-oxaloacetate transaminase and malate dehydrogenase were obtained 
from Boehrmger, Mannheim, Germany The latter enzymes were dialyzed against 
20 mM potassium phosphate buffer, containing 1 mM EDTA, pH 6.7, to remove 
ammonium sulphate. 
Instagel was purchased from Packhard Instrument Co., Chicago, 111., U.S.A. 
4.3. RESULTS 
4.3.1. Citrio acid cycle flux during pyrvvate oxidation 
Changes in concentration of citric acid cycle intermediates were measured 
after various periods of incubation to investigate citric acid cycle flux in 
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skeletal muscle mitochondria during pyruvate plus malate oxidat ion. Oxidation 
of pyruvate is accompanied by a decrease in the concentration of malate, which 
is due to accumulation of 2-oxoglutarate and succinate (Fig. 4.1). 
u m o l / m g protein 
θ-i 
pyruvate 
utilization 
1 г-
15 20 
time (mm ) 
Fig. 4.1. Utilization of pyruvate and malate and accumulation of 2-oxogluta-
rate and succinate during oxidation of pyruvate plus malate. 
Rat skeletal muscle mitochondria (0.13 mg protein) were incubated in the basic 
incubation medium (final volume 1 ml) supplemented with 1 mM pyruvate and 1 mM 
malate. Incubations were terminated at the times indicated. 
Eventually a steady state may be reached, during which there is no further 
accumulation of 2-oxoglutarate and succinate nor a further utilization of 
malate, but the rate of pyruvate oxidation remains constant. The sum of the 
accumulated 2-oxoglutarate and succinate equals the amount of malate utilized. 
At any time, citrate, isocitrate and fumarate were not detectable. Fluxes 
through various segments of the citric acid cycle were calculated from the 
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changes i n c o n c e n t r a t i o n s o f i n t e r m e d i a t e s ( F i g . 4.2) 
MEDIUM 
pyruvate 
malate 
6.5 
32 
succinate •4-
2-oxoglutarate 4 -
MITOCHONDRIAL MATRIX 
-• pyruvate • acetyl Co A 
-• malate 
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2.1 succinate 
.5.5 
J 0 2-oxoglutarate 
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citrate 
Fig. 4.2. Citric acid cycle flux in rat skeletal muscle mitochondria oxidizing 
pyruvate plus malate. 
Fluxes through the various segments of the citric acid cycle (дтоі/mg protein) 
were calculated from the observed changes in metabolite concentrations between 
0 and 20 min of the experiment shown in Fig. 4.1. 
Since no detectable accumulation of citrate and isocitrate takes place, the 
rate of pyruvate oxidation may be assumed to equal the rate of 2-oxoglutarate 
synthesis. Fluxes through 2-oxoglutarate dehydrogenase and succinate dehydro­
genase catalyzed reactions can be calculated from the rate of 2-oxoglutarate 
synthesis and the accumulation of 2-oxoglutarate and succinate. 
Transport of 2-oxoglutarate and succinate across the mitochondrial membrane 
takes place as a 1:1 exchange with malate (12-14). Since the decrease in 
malate concentration equals the sum of the concentrations of the accumulated 
2-oxoglutarate and succinate, accumulation of these intermediates was assumed 
to take place in the extra-mitochondrial space, as was shown for rat heart 
mitochondria (1-3). 
The possibility that the 2-oxoglutarate accumulation was due to contamination 
of pyruvate with parapyruvate (15), a powerfull inhibitor of the 2-oxogluta­
rate dehydrogenase complex (16), was excluded by the following experiment. 
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Mitochondria were incubated with 1 mM malate and pyruvate in concentrations 
ranging from 1 to 10 mM. If pyruvate should be contaminated with parapyruvate, 
the increase in parapyruvate concentration should result in an increased in-
hibition of 2-oxoglutarate dehydrogenase. However, no effect of increasing 
pyruvate concentrations was observed on 2-oxoglutarate accumulation (data not 
shown). 
4.3.2. Fluxes through the c-itvic acid ayote and the reoonst-ituted malate-
aspartate shuttle 
2-0xoglutarate is an intermediate of two important pathways of skeletal muscle 
metabolism. It can be oxidized by the 2-oxoglutarate dehydrogenase complex and 
it can also be used extra-mitochondrially in the reactions of the malate-
aspartate shuttle, which is one of the mechanisms for the transfer of reducing 
equivalents across the mitochondrial membrane (14,17). The observed accumula-
tion of 2-oxoglutarate at the expense of malate (Fig. 4.1) may result from the 
absence of the cytosolic components of the malate-aspartate shuttle in the 
incubation medium. To investigate this possibility, an experiment was per-
formed in which the malate-aspartate shuttle was reconstituted by addition of 
aspartate, NADH, glutamate-oxaloacetate transaminase and malate dehydrogenase 
to the incubation medium of a mitochondrial suspension oxidizing pyruvate plus 
malate. 
Fluxes through the citric acid cycle and the malate-aspartate shuttle were 
calculated from the measured changes in concentration of pyruvate, malate, 2-
oxoglutarate, glutamate, succinate and NAD after 20 min of incubation (Fig. 
4.3). 
Reconstitution of the shuttle eliminated 2-oxoglutarate accumulation. Instead, 
glutamate accumulated. Still considerable accumulation of succinate took 
place·. Flux through the cytosolic glutamate-oxaloacetate transaminase and 
malate dehydrogenase, calculated from the rate of NAD formation, was twice 
the flux through the citric acid cycle span from 2-oxoglutarate to oxalo-
acetate during the 20 min of incubation. 
14 
4.3.3. Measurement of citric acid cycle activity with C-labeled substrates 
Information concerning citric acid cycle activity can also be obtained by 
14 14 
measuring the rate of CO^ production from C-labeled substrates. The 
results obtained with this technique in rat and human skeletal muscle mito-
chondria are presented in Table 4.1. 
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MEDIUM MITOCHONDRIAL MATRIX 
* pyruvate - ;—• acetyl CoA 
NADH 
oxaloacetate 4 
citrate 
2-oxoglutarate 4 
2-oxoglutarate 
J 
Fig. 4.3. Fluxes through the citric acid cycle and the reconstituted malate-
aspartate shuttle. 
Rat skeletal muscle mitochondria (0.12 mg protein) were incubated for 20 min 
in the basic incubation medium (final volume 1 ml) supplemented with 1 mM 
pyruvate, 1 mM malate, 2mM NADH, 5 mM aspartate, 5 U glutamate-oxaloacetate 
transaminase and 12 U malate dehydrogenase. 
Fluxes (мтоі/тд protein) through the citric acid cycle and the malate-aspar-
tate shuttle were calculated from the measured changes in concentration 
between 0 and 20 min of pyruvate (-881 nmoles/ml), malate (-200 nmoles/ml), 
2-oxoglutarate (0 nmoles/ml), succinate (+242 nmoles/ml), glutamate (+349 
nmoles/ml) and NAD+ (+703 nmoles/ml). 
CO- production was measured after incubation with II- Clpyruvate, Ш- Cl 
malate and [1- C]2-oxoglutarate. With [1- Clpyruvate as substrate C0 2 is 
liberated at the pyruvate dehydrogenase complex. CO^ production from lU- C] 
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malate was measured in the presence of malonate to prevent recycling of malate 
14 through the cycle. COg is liberated both at isocitrate dehydrogenase as well 
as at 2-oxoglutarate dehydrogenase. In the presence of [U- Clmalate and 
arsenite, CO- is only liberated at isocitrate dehydrogenase. With [1- C] 
2-oxoglutarate the activity of the 2-oxoglutarate dehydrogenase complex is 
measured. To compare the citric acid cycle activity with the activity of the 
pyruvate dehydrogenase complex under identical conditions, malonate was also 
added to the incubations with tl- Clpyruvate plus malate (Table 4.1). Both in 
rat and human muscle mitochondria the rates of pyruvate oxidation are lower in 
the presence of malonate. 
TABLE 4.1. 
1 4 C 0 2 PRODUCTION FROM [1-
14C]PYRUVATE, IU-14ClMALATE AND ll-14C]2-0X0GLUTARATE 
Assays were performed in the basic incubation medium, final volume 0.5 ml and 
containing approximately 30 дд mitochondrial protein. Additions were made as 
follows: pyruvate 1 mM, malate 1 mM, 2-oxoglutarate 1 mM, acetyl carni tine 2 
mM, malonate 5 mM and arsenite 2 mM. The assays contained approximately 0.2 
pCi of the labeled substrate. Values shown (expressed as μπιοί C0?/mg 
protein.h) are the means + S.D. of the number of experiments shown in the 
parentheses. 
Addition Rat Human 
[1-14C]pyruvate + malate 10.1+1.2(6) 6 . 3 + 1 . 3 ( 6 ) 
[1-14C]pyruvate + malate + malonate 8.5 + 0.9 (6) 4.9 + 1.8 (6) 
[U-14C]malate + pyruvate + malonate 15.4 + 1.4 (6) 6.5 + 1.7 (6) 
[U- CJmalate + acetylcarnitine + malonate 5.6 + 0.8 (6) 6.3 + 1.7 (6) 
[U- Clmalate + acetylcarnitine + arsenite 3.1 + 0.3 (6) 3.8 + 0.9 (6) 
[1-14C]2-oxoglutarate 14.9 + 1.9 (6) 11.1 + 3.0 (4) 
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C0 ? production rates from lU- Clmalate are about equal with pyruvate or 
acetyl carni ti ne as acetyl donor in human muscle mitochondria, whereas the rate 
14 г 14 ι 
of COp production from lU- CJmal ate with pyruvate is about three fold 
higher than that with acetylcarnitine in rat muscle mitochondria. The latter 
suggests that acetylCoA is generated at a three fold higher rate from pyruvate 
than from acetylcarnitine in rat muscle mitochondria, whereas these rates are 
equal in human muscle mitochondria. 
Both in rat and human muscle mitochondria a divergence exists between the 
ι 14 
activity of the pyruvate dehydrogenase complex (measured with U - CI pyruvate 
plus malate) and the activity of isocitrate dehydrogenase (measured with 
[U- Clmalate plus acetylcarnitine and arsenite). In rat muscle mitochondria 
this may be explained by the different rates at which acetylCoA is generated 
from pyruvate and acetylcarnitine. The divergence in human muscle mitochondria 
may be caused by the fact that either less acetylCoA than has been formed 
enters the citric acid cycle or that citrate accumulates. To investigate this 
latter possibility, human muscle mitochondria were incubated with malate, 
r 14 ι 
malonate and 12- CJpyruvate. After incubation, metabolites were separated by 
high voltage electrophoresis. Radioactivity was present in pyruvate, 2-oxoglu-
tarate and succinate, but " C-citrate was not detectable (Fig. 4.4). [2- Cl 
pyruvate was used in this experiment since citrate comigrates with malate 
during high voltage electrophoresis under the used conditions. 
4.4. DISCUSSION 
4.4.1. Acoumulation of 2-oxoglutarate and succinate during pyruvate plus 
matate oxidation 
Oxidation of pyruvate plus malate by rat skeletal muscle mitochondria is 
accompanied by accumulation of 2-oxoglutarate and succinate and utilization of 
malate. From the changes in concentrations of metabolites (Fig. 4.1) it can be 
concluded that the citric acid cycle in muscle mitochondria can be divided 
into three segments: entry of acetylCoA to 2-oxoglutarate synthesis, oxidation 
of 2-oxoglutarate to succinate and further oxidation of succinate to malate. 
Moreover, it appears that the fluxes through these various segments are diffe­
rent, especially during the initial stage of incubation. During prolonged 
incubation the rates of 2-oxoglutarate and succinate accumulation as well as 
the rate of malate utilization decrease, suggesting that ultimately a steady 
state will be reached. No detectable accumulation of citrate and isocitrate 
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took place, which may be related to the absence of a tr icarboxylate trans-
locase in muscle mitochondria (18). 
5 0 -
4 0 -
3 0 -
2 0 -
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succinate pyruvate 
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2-oxo 
glut arate 
j » « » « f « « » » y « 
10 15 20 25 30 35 
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14, Fig. 4.4. Incorporation of radioactivity from 12- Clpyruvate in citric acid 
cycle intermediates. 
Human skeletal muscle mitochondria (0.22 mg protein) were incubated for 15 min 
in the basic incubation medium (final volume 1 ml) supplemented with 1 mM 
malate, 5 mM malonate and 1 mM pyruvate (0.25 дСі [2- С] pyruvate). High 
voltage electrophoresis of a neutralized perchloric acid sample of the incuba­
tion medium and subsequent determination of radioactivity were performed as 
described under Materials and Methods. If present, 
at about 5 cm from the origin. 
14 C-citrate should be found 
2-0xoglutarate and succinate are cycle intermediates which can either be 
oxidized by the reactions of the citric acid cycle or can be transported 
across the mitochondrial membrane in exchange for malate. The accumulation of 
these intermediates is, therefore, the resultant of the relative activities of 
their transport and oxidation pathways. The activity of the 2-oxoglutarate 
dehydrogenase complex is low during pyruvate oxidation (7), which is probably 
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due to competition for CoA between the pyruvate and 2-oxoglutarate dehydro­
genase complexes. The transport of 2-oxoglutarate and succinate is stimulated 
by malate (12-14) and will be most active during the initial stage of incuba­
tion when the extra-mitochondrial concentrations of 2-oxoglutarate and succi­
nate are low. During incubation the rate of accumulation of these inter­
mediates decreases, whereas the rate of pyruvate oxidation remains constant 
(Fig. 4.1). Hence, an increasing part of the oxaloacetate necessary for pyru­
vate oxidation is derived from malate regenerated through citric acid cycle 
activity during incubation. 
Pyruvate and NADH are generated in stoichiometric amounts in the cytosol from 
lactate taken up from the bloodstream or produced during glycolysis. There­
fore, oxidation of pyruvate will be coupled to the oxidation of extra-mito­
chondrial NADH. One of the mechanisms catalyzing the transport of reducing 
equivalents across the mitochondrial membrane is the malate-aspartate shuttle 
(14,17,19). Operation of this shuttle involves the exchange of extra-mitochon­
drial malate for intra-mitochondrial 2-oxoglutarate. In the presence of the 
reconstituted malate-aspartate shuttle a considerable part of the oxaloacetate 
required for pyruvate oxidation is derived from malate formed through the 
reactions of this shuttle during the 20 min of incubation (Fig. 4.3). The 
accumulation of 2-oxoglutarate is eliminated but now a rise in glutamate and a 
decrease in aspartate levels is observed. The changes in concentration of 
these latter metabolites are in the same direction as observed in heart muscle 
during transition from substrate-free perfusion to perfusion with glucose plus 
insulin (19). 
The possible physiological relevance of the accumulation of succinate is not 
clear. There are no known extra-mitochondrial pathways in succinate meta­
bolism. In rat heart mitochondria incubated with pyruvate also accumulation of 
succinate takes place (1-4), whereas no accumulation of succinate was reported 
during perfusion of rat heart with glucose plus insulin (19). 
4.4.2. Measurement of огігъс acid cycle activity with C-labeled substrates 
Information concerning citric acid cycle activity during pyruvate plus malate 
oxidation in muscle mitochondria can also be obtained by measuring the rate of 
14 14 г 14 ι 
CO, production from C-labeled pyruvate or malate. When using 12- CJpyru-
14 
vate as substrate, CO, is liberated after one full turn of the cycle (20). 14 This means that С is stored in accumulated 2-oxoglutarate and succinate and 
is subject to considerable label dilution by the large pool of unlabeled 
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malate before any CCL'is liberated. When using [U- Cimai ate as substrate, 
14 г 14 ι 
CCL is liberated during the first turn of the cycle. Mixing of the IU- CI 
malate pool with citric acid cycle derived malate can be prevented by addition 
of malonate. On base of these considerations citric acid cycle activity was 
measured with [U- Clmalate as labeled substrate. 
The decrease in CCL production from [1- C]pyruvate by malonate may be 
explained by competition of malate and malonate for transport by the dicarbo-
xylate translocase (13). This will result in a decrease in the amount of 
malate transported and hence the effective malate concentration will be 
lowered, resulting in a decreased stimulation of pyruvate oxidation. 
The dissimilar rates of CCL production from [U- Clmalate with pyruvate and 
acetylcarnitine in rat muscle mitochondria (Table 4.1) indicate that the pyru­
vate dehydrogenase activity is higher than the carnitine acetyl transferase 
activity. In human muscle mitochondria these activities appear to be about 
equal. 
The divergence between the activity of pyruvate dehydrogenase and isocitrate 
dehydrogenase in human muscle mitochondria could not be explained by accumula­
tion of citrate. Such an accumulation is not likely since muscle mitochondria 
do not possess a tricarboxylate translocase (18). Furthermore, in human muscle 
mitochondria citrate synthase and isocitrate dehydrogenase activities are 
about equal (21). It seems therefore that part of the acetylCoA formed by the 
pyruvate dehydrogenase complex is converted into acetate, as was found with 
mitochondria from rat heart (1,22,23) and house fly flight muscle (24). 
14 Parallel incubations of human muscle mitochondria with lU- Clmalate and 
either pyruvate or acetylcarnitine will be the best means of obtaining infor­
mation concerning citric acid cycle activity in the span between entry of 
acetylCoA and 2-oxoglutarate oxidation, since acetylCoA is supplied through 
two independent pathways. If these incubations are performed differentiation 
will be possible between a defect in pyruvate dehydrogenase, carnitine acetyl-
transferase and the first segment of the citric acid cycle. The activity of 
the second segment of the cycle, the oxidation of 2-oxoglutarate to succinate, 
can be measured with [1- Cl2-oxoglutarate as substrate. The activity of the 
14 
enzymes of the last segment cannot be measured by the rate of CCL production 
from labeled substrates since there are no decarboxylation steps involved in 
the oxidation of succinate to malate. However, the stimulation of the rate of 
CO2 production from 11- C]pyruvate by succinate or fumarate (Chapter 3) may 
be taken as a measure of the activities of the enzymes of this last segment of 
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the citric acid cycle. 
4.5. SUMMARY 
Citric acid cycle activity was investigated in skeletal muscle mitochondria 
oxidizing pyruvate plus malate. The accumulation of cycle intermediates 
indicates that the citric acid cycle operates in three segments: entry of 
acetylCoA to 2-oxoglutarate, 2-oxoglutarate to succinate and succinate to 
malate. 
By reconstitution of the malate-aspartate shuttle the accumulation of 2-oxo-
glutarate is eliminated and glutamate accumulates. 
Due to the accumulation of cycle intermediates overall flux through the citric 
acid cycle cannot be measured in skeletal muscle by determining the rate of 
14 14 
СО« production from C-labeled substrates. The activity of the first 
ι 14 ι 
segment of the cycle can be measured with IU- dmalate as substrate. Oxida-14 
tion of 2-oxoglutarate to succinate can be assayed with [1- C] 2-oxoglutarate. 
The stimulation of CCk production from [1- C]pyruvate in the presence of 
succinate or fumarate gives an indication of the activities of the enzymes of 
the last segment of the citric acid cycle. 
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CHAPTER 5 
RECONSTITUTION OF MALATE-ASPARTATE AND c-GLYCEROPHOSPHATE SHUTTLE ACTIVITY IN 
RAT SKELETAL MUSCLE MITOCHONDRIA 
5.1. INTRODUCTION 
The inner mitochondrial membrane is impermeable for NADH (1). Therefore, 
reducing equivalents generated in the cytosol must be transported across the 
inner mitochondrial membrane in some other form before they can be oxidized by 
the mitochondrial electron transport chain. A number of shuttle mechanisms 
have been postulated to carry out this process by transporting reducing equi­
valents across the mitochondrial membrane in the form of a reduced substrate 
which is oxidized within the mitochondrion and then transported back to the 
cytosol to become reduced again (2-4). Among these shuttles the malate-aspar-
tate shuttle and the a-glycerophosphate shuttle are thought to be the most 
important ones (5). Operation of the a-glycerophosphate shuttle does not 
actually involve substrate translocation across the inner mitochondrial 
membrane since the enzyme ^-glycerophosphate dehydrogenase is located on the 
outer site of the mitochondrial inner membrane (6). 
In this chapter the transport of reducing equivalents across the mitochondrial 
membrane of rat skeletal muscle mitochondria was studied. The malate-aspartate 
shuttle and the a-glycerophosphate shuttle were reconstituted by addition of 
the cytosolic components of these shuttle systems to the incubation medium. 
Shuttle activities were assayed by measuring the rate of NAD formation from 
added NADH. The effect of respiratory chain inhibitors and uncoupler as well 
as the effect of citric acid cycle inhibitors on the activity of the reconsti­
tuted shuttles was investigated. 
5.2. MATERIALS AND METHODS 
Rat skeletal muscle mitochondria were isolated as described in Chapter 3. 
Incubations were performed in the basic incubation medium, final volume 1 ml. 
In those incubations to which FCCP was added, ADP and hexokinase were omitted. 
Incubations were terminated after 10 or 15 min by addition of 0.2 ml 6 M 
нсіо4. 
Reconstitution of malate-aspartate shutt le was performed by addition of 10 mM 
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glutamate, 2 mM malate, 5 mM aspartate, 5 units glutamate-oxaloacetate trans­
aminase and 12 units malate dehydrogenase. The ^-glycerophosphate shuttle was 
reconstituted by addition of 10 mM L-glycerol-3-phosphate and 3 units 
«-glycerophosphate dehydrogenase. Initial NADH concentration was 5 mM with 
both reconstituted shuttles. Under all conditions tested, incubations were 
also performed in the absence of reconstituted shuttle systems to correct for 
NADH oxidation which was not linked to shuttle activity. 
Glutamate-oxaloacetate transaminase, (»-glycerophosphate dehydrogenase and 
malate dehydrogenase were obtained from Boehringer, Mannheim, W-Germany and 
were dialyzed against 20 mM potassium phosphate buffer, containing 1 mM EDTA, 
pH 6.7, to remove ammonium sulphate present in these commercial preparations. 
NAD and glucose-6-phosphate were assayed in neutralized perchloric acid 
samples of the incubation medium with alcoholdehydrogenase and ethanol (7) and 
with NADP and glucose-6-phosphate dehydrogenase (8), respectively. 
5.3. RESULTS 
5.3.1. Effect of respiratory chain inhibitors and uncoupter on shuttle activi­
ties 
The activity of the reconstituted malate-aspartate shuttle and α-glycero­
phosphate shuttle was determined by measuring the rate of formation of NAD 
from NADH. Preliminary experiments showed that with the concentrations of 
glutamate, malate, aspartate and α-glycerophosphate used, maximal rates of 
NAD formation were obtained with the respective shuttles. Under the condi­
tions employed the rate of NAD formation was linear with respect to time and 
amount of protein present with both reconstituted shuttle systems (Fig. 5.1). 
The rate of NAD formation by the reconstituted malate-aspartate shuttle is 
about 50 % greater than that observed with the reconstituted a-giycero-
phosphate shuttle (Table 5.1). Simultaneous reconstitution of both shuttle 
systems results in a rate of NAD formation which is the sum of the rates 
obtained with the separate shuttles. The activity of the malate-aspartate 
shuttle is completely blocked by addition of rotenone, whereas no effect on 
"-glycerophosphate shuttle activity is observed. Antimycin A inhibits both 
reconstituted shuttles. The inhibition of malate-aspartate shuttle activity by 
FCCP indicates that this shuttle system is dependent on energy supply, which 
may be explained by the energy linked efflux of aspartate from the mitochon­
dria (9-12). 
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Fig. 5.1. Rate of NAD formation by the reconstituted malate-aspartate 
(o o) and «»-glycerophosphate (x x) shuttle as a function of time 
(mitochondrial protein concentration 180 мд/ml) and as a function of the 
amount of mitochondrial protein (incubation time 15 m m ) . Data were taken from 
one representative experiment. 
5.3.2. Stoichionetry between IAD and AIP formation 
To assay the stoichiometry between shuttle mediated NADH oxidation and ATP 
formation, glucose-6-phosphate formation was measured in addition to NAD 
formation. The ratio between glucose-6-phosphate and NAD formation by the 
"-glycerophosphate shuttle was 1 20 + 0.06 (mean + S.D , n=3). A (theore­
tically impossible) ratio of 4.55 for NADH oxidation was obtained with the 
malate-aspartate shuttle (Table 5.2). This may be explained by assuming that 
not only extra-mitochondrial NADH but also intra-mitochondrially generated 
NADH is oxidized. To investigate this possibility, the effect of inhibitors of 
citric acid cycle activity was tested. Addition of arsemte to the incubation 
medium lowered the rate of glucose-6-phosphate production and increased the 
rate of NAD formation, resulting in a ratio between glucose-6-phosphate and 
NAD formation of 1.95. The mean value obtained under this condition was 2.03 
+ 0.15 (mean + S.D., n=3). Addition of malonate did not influence the rates of 
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TABLE 5.1. 
EFFECT OF RESPIRATORY CHAIN INHIBITORS AND UNCOUPLER ON SHUTTLE ACTIVITIES 
Rat skeletal muscle mitochondria (final concentration about 0.1 mg protein/ml) 
were incubated in the medium described under Materials and Methods. Inhibitor 
concentrations were 1 дд/ті rotenone, 1 мд/ті antimycin A and 2 mM KCN. Final 
concentration of FCCP was 0.2 μΜ. Values are the means + S.D. of three or four 
separate experiments. 
Additions 
None 
Rotenone 
Antimycin A 
FCCP 
Shuttle activi 
Malate-aspartate 
20.2 + 3.0 
<1 
<1 
(1 
ty (лтоі NAD+ formed/mg protein.h) 
a-glycerophosphate 
13.0 + 2.2 
13.3 + 1.9 
(1 
14.8 + 2.2 
Malate-aspartate + 
^-glycerophosphate 
31.4 + 4.3 
13.7 + 1.7 
<1 
21.8 + 3.7 
TABLE 5.2. 
STOICHIOMETRY BETWEEN THE FORMATION OF GLUCOSE-6-PHOSPHATE AND NAD+ BY THE 
RECONSTITUTED MALATE-ASPARTATE SHUTTLE 
Rat skeletal muscle mitochondria (final concentration 0.11 mg protein/ml) were 
incubated in the medium as described under Materials and Methods. Where 
indicated arsenite and malonate were added in a concentration of 2 mM and 5 
mM, respectively. 
Addition Glucose-6-phosphate NAD 
(μπιοΐ/πκ; protein.h) 
Glucose-6-phosphate/NAD 
r a t i o 
None 
Arsenite 
Malonate 
119.2 
67.4 
119.7 
26.2 
34.6 
26.1 
4.55 
1.95 
4.59 
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NAD and glucose-6-phosphate formation. 
5.3.3. Interaction between malate-aspartate and ^-glycerophosphate shuttles in 
the presence of uncoupler 
In the presence of FCCP, simultaneous reconstitution of both shuttles shows a 
rate of NAD formation which exceeds the sum of the rates measured with the 
separate shuttles (Table 5.1). To investigate whether this increment in NAD 
formation was due to an increase in activity of the malate-aspartate shuttle, 
of the «-glycerophosphate shuttle or of both shuttles, the experiment 
presented in Table 5.3 was performed. It clearly shows that the rate of NAD 
formation in the presence of FCCP and both shuttles is reduced by addition of 
rotenone to the rate measured with the α-glycerophosphate shuttle separately, 
which indicates that the increment in NAD formation originates from malate-
aspartate shuttle activity. 
TABLE 5.3. 
EFFECT OF ROTENONE ON SHUTTLE ACTIVITIES IN UNCOUPLED MITOCHONDRIA 
Rat skeletal muscle mitochondria (final concentration 0.13 mg protein/ml) were 
incubated in the medium described under Materials and Methods supplemented 
with 0.2 juM FCCP. Rotenone (1 дд/ті) was added as indicated. Activities of the 
shuttle systems are given in дтоі NAD formed/mg protein.h. 
Shuttle system - rotenone + rotenone 
Malate-aspartate <1 <1 
"-Glycerophosphate 16.9 16.3 
Malate-aspartate + 23.9 16.4 
^-glycerophosphate 
60 
5.4. DISCUSSION 
In the present study, rat skeletal muscle mitochondria were incubated with a 
high concentration of NADH to measure the activity of the reconstituted 
malate-aspartate and a-glycerophosphate shuttle. Previous investigations were 
performed with NADH regenerating systems containing NAD and either lactate 
plus lactate dehydrogenase (9) or ethanol plus alcohol dehydrogenase (13). The 
former system has a low capacity to regenerate NADH, and some of the pyruvate 
formed may undergo further oxidation through the citric acid cycle, thereby 
reducing the amount of oxaloacetate available for malate-aspartate shuttle 
activity. The latter system suffers from the disadvantage that under condi-
tions where respiratory chain inhibitors are used acetaldehyde accumulates in 
the incubation medium which subsequently inhibits alcohol dehydrogenase activi-
ty (14). These problems are circumvented by incubation with NADH. The linear 
rate of NAD production measured with respect to the amount of protein 
indicates that the rate of NAD formation is determined by the activity of the 
mitochondria. 
The effect of rotenone on shuttle activities (Table 5.1) indicates that NADH 
oxidation mediated by the malate-aspartate shuttle proceeds through the NADH 
dehydrogenase region of the respiratory chain whereas reducing equivalents 
transported by the ^-glycerophosphate shuttle enter the respiratory chain 
distal to the rotenone block. The latter is in contrast to the inhibition of 
^-glycerophosphate shuttle activity by rotenone in rat liver mitochondria 
observed by Cederbaum et al. (13). However, those experiments were performed 
with a NADH regenerating system using alcoholdehydrogenase. 
Inhibition of 2-oxoglutarate dehydrogenase by arsenite has a dual effect on 
the stoichiometry of the malate-aspartate shuttle: the rate of NAD formation 
increases and the rate of glucose-6-phosphate formation decreases. No effect 
is observed by the inhibition of succinate dehydrogenase by malonate (Table 
5.2). This means that the presence of arsenite prevents that part of the 2-
oxoglutarate generated intra-mitochondrially by the glutamate-oxaloacetate 
transaminase is oxidized to succinate. This results in an increased amount of 
2-oxoglutarate available for shuttle activity and reduces the amount of ATP 
formed from oxidation of intra-mitochondrial NADH. 
Uncoupling is known to result in an inhibition of aspartate efflux from mito-
chondria (9-12). This efflux could be restored in heart muscle mitochondria by 
addition of ATP and was oligomycin sensitive under this condition which 
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indicates that glutamate-aspartate exchange requires energization of the mito-
condrial membrane (10). In our experiments a mean value of about 2 was found 
for the ratio between glucose-6-phosphate and NAD formation during malate-
aspartate shuttle activity in the presence of arsenite, indicating that for 
each molecule of NADH oxidized and hence for each molecule of extra-mitochon-
drial glutamate exchanged for intra-mitochondrial aspartate one molecule of 
ATP is needed. Simultaneous reconstitution of both shuttles in uncoupled rat 
skeletal muscle mitochondria results in a partial restoration of malate-
aspartate shuttle activity (Table 5.3) of about 7 мтоі NADH oxidized per mg 
protein.h. This activity needs a supply of 7 μπιοί ATP/mg protein.h. which can 
only be supplied by (»-glycerophosphate shuttle activity. Since the latter 
proceeds at a mean rate of about 13 дтоі/тд protein.h. and in the absence of 
FCCP with a ratio between glucose-6-phosphate and NAD formation of 1.20, it 
can be calculated that about 40 % of the energy arising from α-glycero­
phosphate shuttle activity is not wasted in the presence of uncoupler but used 
to support malate-aspartate shuttle activity. Further investigations are 
needed to elucidate the mechanism which enables the glutamate-aspartate trans-
locase to perform energy-linked transport in the presence of uncoupler and the 
reconstituted ^-glycerophosphate shuttle. 
5.5. SUMMARY 
In this chapter transport of reducing equivalents across the mitochondrial 
membrane of skeletal muscle mitochondria was studied. Rat skeletal muscle 
mitochondria were incubated with NADH and the cytosolic components of the 
malate-aspartate shuttle or the a-glycerophosphate shuttle. The capacity for 
NADH oxidation was about 50 % higher with the malate-aspartate shuttle than 
with the oi-glycerophosphate shuttle. During malate-aspartate shuttle activity 
considerable amounts of succinate are formed from 2-oxoglutarate, which is 
generated intra-mitochondrially through the glutamate-oxaloacetate trans­
aminase. This reduces the amount of 2-oxoglutarate available for shuttle 
activity and limits the rate of oxidation of extra-mitochondrial NADH. 
Furthermore, a hitherto unknown interaction between the malate-aspartate and 
the α-glycerophosphate shuttle was found, which decreases the inhibition of 
malate-aspartate shuttle activity caused by uncoupler. 
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CHAPTER 6 
MEASUREMENT OF CYTOCHROMES IN HUMAN SKELETAL MUSCLE MITOCHONDRIA ISOLATED FROM 
FRESH AND FROZEN-STORED MUSCLE SPECIMENS 
6.1. INTRODUCTION 
Measurement of cytochromes in human skeletal muscle mitochondria may be of 
diagnostic value in the case of patients suffering from a "mitochondrial myo-
pathy". However, few reports appeared in the literature concerning cytochromes 
in human skeletal muscle mitochondria. 
Makinen and Lee (1) and DiMauro et al. (2) measured difference spectra of 
human skeletal muscle mitochondria at the temperature of liquid nitrogen. The 
absolute amount of cytochromes was calculated after correction for the in-
crease in absorbance due to the low temperature. This correction was based on 
data obtained from experiments with rat and canine skeletal muscle mitochon-
dria (1). 
Spiro et al. (3, 4) measured cytochromes in human skeletal muscle mitochondria 
at room temperature. However, they reported the ratio between the different 
cytochromes but not the absolute amount. A decrease in cytochrome content in 
human muscle mitochondria was reported by several authors (4-9). 
In this study, human skeletal muscle mitochondria were isolated from small 
muscle biopsy specimens. Difference spectra of cytochromes were recorded at 
room temperature after reduction of the cytochromes with dithionite or with 
succinate plus KCN. The latter method was used to avoid reduction of hemo-
globin or myoglobin which was always present in amounts which caused a heavy 
contamination of the spectra. Also, muscle specimens were stored at -70° prior 
to the isolation of mitochondria and the subsequent measurement of the cyto-
chrome spectra. The effect of storage of muscle specimens at -70° on the cyto-
chrome content finally present in the mitochondria was investigated. 
6.2. MATERIALS AND METHODS 
Human skeletal muscle specimens (1.5-2.0 g) were obtained from patients with 
no known history of neuromuscular disease. Rat skeletal muscle was obtained 
from the hind leg of male Wistar rats, weighing 150-200 g. The muscle speci-
mens were placed immediately in an ice-cold medium, containing 250 mM sucrose, 
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2 mM EDTA, 10 тМ Tris-HCl and 50 U/ml heparin, pH 7.4 (SETH-medium), or were 
stored at -70 . Mitochondria were isolated from fresh and from stored muscle 
tissue (after thawing) as described in chapter 3. 
Spectra. Difference spectra between the reduced and the oxidized forms of the 
cytochromes were recorded at room temperature on а Сагу 118C double-beam 
recording spectrophotometer. Both the reference and the sample cuvette 
(optical pathway 10 mm) were filled with a suspension containing 0.3-0.6 mg 
mitochondrial protein per ml, 24 mM potassium phosphate, 2 mM EDTA, 10 mM 
Tris-HCl, 60 mM KCl, 7 mM MgCl2, 90 mM sucrose, 1.6 mM ADP, final pH 7.4. 
Under this condition the mitochondria are in the fully oxidized state or State 
2 (10). 
Reduction of the cytochromes in the sample cuvette was achieved by one of the 
following two methods: 
a. 10 mM succinate plus 1 дд antimycin A was added to the mitochondrial 
suspension in the sample cuvette and the spectrum was recorded. Hereafter, 
a few grains of dithionite were added and the spectrum was recorded again. 
b. 10 mM succinate plus 1 mM KCN was added to the sample and the spectrum was 
recorded. 
For calculation of the mitochondrial cytochrome content the following 
extinction coefficients were used: cytochrome aao¿ecn5_c-5n= 16.5 mM" (11), 
cytochrome ba«cg5_57c= 17.9 mM" (12) and cytochrome c+c, Дессп.слгг 19.0 
mM"1 (13). 
мл} 
Protein was determined by the method of Lowry et а Г '. Statistical analyses were 
performed with the Student's t test. 
6.3. RESULTS 
6.3.1. Spectra 
Fig. 6.1 shows the difference spectrum of human skeletal muscle mitochondria. 
After reduction with succinate plus antimycin A the spectrum of cytochrome b 
is recorded (middle curve). The «»-band of cytochrome b has its maximum at 565 
nm, whereas the r-band can be seen at 431 nm. Subsequent addition of dithio­
nite results in reduction of all the cytochromes as shown in the upper curve. 
The α-bands of cytochrome aa, and cytochrome c+c, have their maxima at 606 nm 
and 551 nm, respectively. The 7-band of cytochrome aa., has its maximum at 445 
nm. Subtraction of the spectrum of cytochrome b from the spectrum obtained 
after dithionite reduction gives the spectrum of cytochrome aa, and c+c, 
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(lower curve). 
ΔΑ= 0.010 ΔΑ= 0.002 
550 600 650 
Wavelength (nm) 
Fig. 6.1. Difference spectrum of human skeletal muscle mitochondria. After 
addition of succinate plus antimycin A to the sample cuvette the spectrum of 
cytochrome b is recorded (middle curve). Subsequent addition of dithionite 
reduces all the cytochromes (upper curve). The lower curve shows the diffe­
rence spectrum obtained after reducing the mitochondrial suspension in the 
sample cuvette with succinate plus antimycin A followed by dithionite and the 
suspension in the reference cuvette with succinate plus antimycin A. For 
further experimental details see text. 
In Fig. 6.2 the spectrum of rat skeletal muscle mitochondria is shown. 
Comparing these spectra (Figs. 6.1 and 6.2) it can be seen that addition of 
dithionite to the human mitochondrial suspension results in an increase in the 
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absorbance difference between the peak at 565 nm and the trough at 575 nm. 
Moreover, there is a marked increase in the absorbance at 431 nm which does 
not allow resolution of the T-band of cytochrome c+c, at 420 nm (lower 
curves). 
ΔΑ= 0.005 ΔΑ= 0.002 
550 600 650 
Wavelength (nm) 
Fig.·6.2. Difference spectrum of rat skeletal muscle mitochondria. The assay 
conditions were the same as described for Fig. 6.1. 
This indicates contamination of the mitochondrial suspension with hemoglobin 
(Hb) or myoglobin (Mb). .The dithionite reduced minus oxidized difference 
spectra of human Hb and Mb are shown in Fig. 6.3. Since these difference 
spectra of human Hb and Mb are very similar it is not possible to distinguish 
between spectra from Hb contaminated and Mb contaminated mitochondrial sus­
pensions. It can be seen in Fig. 6.1 that this contamination mostly affects 
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the a- and 7-band of cytochrome b, which is the reason that cytochrome b was 
measured separately with succinate plus antimycin A. By reducing the cyto­
chromes with succinate plus KCN instead of dithionite the problem of contami­
nation is eliminated since there is no reduction of Hb and Mb under this 
condition. 
ΔΑ= 0.05 
400 450 
ΔΑ= 0.005 
500 550 600 650 
Wavelength (nm) 
Fig. 6.3. Difference spectrum of human hemoglobin (upper curve) and human 
myoglobin (lower curve). 
Reduction was achieved by addition of dithionite. 
6.3.2. Cytochrome content of human skeletal muscle mitochondria 
The cytochrome content of human skeletal muscle mitochondria is presented in 
Table 6.1. The mean values obtained after reduction with succinate plus KCN 
are lower than those obtained after succinate plus antimycin A followed by 
dithionite reduction. The difference is significant (P<0.05) in the case of 
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cytochromes b and c+c,. Although the mean value obtained for cytochrome aa, in 
the presence of succinate plus KCN is lower than in the presence of dithio-
nite, statistical analysis shows this difference to be not significant (P> 
0.05). 
TABLE 6.1. 
CYTOCHROME CONTENT OF HUMAN SKELETAL MUSCLE MITOCHONDRIA 
Values shown are the means + SD of the number of experiments shown in the 
parentheses. 
n.s.: not significant 
Reduction aa, b c+c, aa, b c+c 
Method pmoles/mg protein relative amount 
Succinate + 
Antimycin A/ 444 423 906 1.0 0.95 2.04 
dithionite (n=5) + 6 6 + 6 5 + 187 
Succinate + KCN 374 290 648 1.0 0.78 1.73 
(n=8) + 117 + 7 1 + 187 
Ρ n.s. (0.01 (0.05 
It is not always possible to perform measurement of cytochromes immediately 
after taking the muscle biopsy specimen. Therefore, we investigated the effect 
of storage of muscle tissue on the content of cytochromes. Muscle tissue was 
stored for periods up to three months at -70 . After thawing, mitochondria 
were isolated and cytochromes were measured exactly as described for fresh 
muscle specimens. The cytochrome content of these mitochondria is presented in 
Table 6.2. The contamination in mitochondrial suspensions obtained from muscle 
tissue which has been stored at -70° was considerably greater as compared with 
mitochondrial suspensions obtained from fresh muscle tissue. 
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TABLE 6.2. 
CYTOCHROME CONTENT OF HUMAN SKELETAL MUSCLE MITOCHONDRIA ISOLATED FROM MUSCLE 
TISSUE STORED AT -70° 
Values shown are the means + SD of the number of experiments shown in the 
parentheses. 
Reduction aa, b c+c, aa-, b c+c, 
Method pmoles/mg protein relative amount 
Succinate + 
Antimycin A/ 450 488 - 1.0 1.08 
d i th ion i te (n=4) + 5 2 + 107 
1.0 0.79 1.36 Succinate + KCN 
(n=4) 
305 
+ 28 
241 
+ 9 
414 
+ 79 
<0.01 (0.05 
Due to this contamination the cytochrome c+c, peak is poorly resolved after 
dithionite addition and a reliable calculation of the cytochrome c+c, content 
was impossible. Comparison of the cytochrome values obtained after reduction 
with succinate plus KCN with those obtained after reduction with succinate 
plus antimycin A, followed by dithionite reveals again lower values for cyto-
chrome aa-, and cytochrome b in the former method, as was the case with fresh 
muscle. In contrast to mitochondria isolated from fresh muscle specimens, the 
difference in values found for cytochrome aa., is now significant. 
Comparison of the values obtained with succinate plus KCN in fresh and -70 
stored muscle shows a decrease in the relative amount of cytochrome c+c, after 
storage (Table 6.1 and 6.2). 
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6.4. DISCUSSION 
Measurement of cytochrome spectra from human skeletal muscle mitochondria by 
means of dithionite reduced minus oxidized difference spectrophotometry showed 
that the mitochondrial suspension is contaminated with Hb or Mb, in contrast to 
mitochondria isolated from rat skeletal muscle. This contamination could not 
be removed by extensive washing of the mitochondrial fraction during the iso-
lation procedure. Contamination of mitochondrial suspensions with Hb has also 
been described for human liver mitochondria (15). Reduction with succinate 
plus KCN instead of dithionite eliminates the problem of contamination from 
the spectra. 
Significantly higher values were found for cytochrome b and cytochrome c+c, 
after reduction with succinate plus antimycin A followed by addition of 
dithionite as compared with the values found after reduction with succinate 
plus KCN, in contrast to the values found for cytochrome aa, by these methods. 
An explanation for this phenomenon that higher amounts of cytochromes are 
found after reduction with dithionite might be that not all of the cytochromes 
are linked to the respiratory chain, as has been concluded by Sato and 
Hagihara for cytochromes in mouse ascites hepatoma cells (16). An alternative 
explanation may be that the degree of reduction of the cytochromes and thus 
the amount of cytochromes calculated to be present is dependent on the method 
of reduction. This latter explanation is certainly true in the case of cyto-
chrome b. It can be observed (see Tables 6.1 and 6.2) that a much higher 
amount of cytochrome b is measured in the presence of succinate plus antimycin 
A than in the presence of succinate plus KCN. Storage of muscle tissue at -70 
does not result in a loss of cytochrome b and cytochrome aa, from the mito-
chondria as can be concluded from the values found in fresh and stored muscle 
after reduction of the cytochromes with succinate plus antimycin A followed by 
dithionite (Tables 6.1 and 6.2). The values found after reduction with succi-
nate plus KCN in stored muscle are lower than those obtained with dithionite, 
as was the case with fresh muscle. The difference in values found for cyto-
chrome aa, in mitochondria isolated from stored muscle specimens is signifi-
cant in contrast to the difference found with mitochondria isolated from fresh 
muscle tissue. Comparison of the relative amount of cytochromes found after 
reduction with succinate plus KCN in mitochondria isolated from fresh or 
stored muscle tissue reveals a difference in stoichiometry which clearly 
points at a loss of cytochrome c+c, from the mitochondria after storage of the 
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muscle tissue. This may be caused by the much weaker binding of cytochrome с 
to the mitochondrial membrane as compared with the other cytochromes. 
In our opinion measurement of difference spectra of cytochromes is a valuable 
diagnostic tool in the field of muscle disease, especially since its use is 
not restricted to mitochondria isolated from fresh muscle biopsy specimens, 
but it can also be applied to muscle tissue which has been stored at -70°. 
Since preparations of human skeletal muscle mitochondria are contaminated with 
Hb or Mb, the use of dithionite as reductant leads to contaminated spectra 
which can easily be misinterpreted (4) and should therefore be avoided. 
6.5. SUMMARY 
Mitochondria were isolated from small muscle biopsy specimens, and the cyto­
chrome content was calculated from the reduced minus oxidized difference 
spectrum recorded at room temperature. 
From the difference spectra obtained after reduction of the cytochromes with 
dithionite it is concluded that human mitochondrial suspensions are contami­
nated with hemoglobin or myoglobin. 
The cytochrome content calculated after reduction of the cytochromes with 
succinate plus KCN is lower than that obtained after reduction with dithio­
nite, indicating incomplete reduction of the cytochromes by the former method. 
Storage of muscle tissue at -70 before isolation of mitochondria results in a 
loss of cytochrome c+c, from these mitochondria. 
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CHAPTER 7 
THE EFFECT OF EXOGENOUS CYTOCHROME С ON PYRUVATE OXIDATION BY RAT SKELETAL 
MUSCLE MITOCHONDRIA ISOLATED IN SUCROSE OR KCL MEDIUM 
7.1. INTRODUCTION 
Cytochrome с is readily released from the mitochondrial membrane by washing 
mitochondria with hypotonic KCl solutions (1), treatment of mitochondria with 
digitonin (2) or sonification of mitochondrial suspensions during preparation 
of submitochondrial particles (3). 
These results indicate the more labile binding of cytochrome с to the mito­
chondrial membrane as compared with the other cytochromes. 
Loss of cytochrome с from mitochondria results in a diminished oxidative capa­
city of the mitochondria which can be restored upon addition of cytochrome с 
(4, 5). 
In a recent report. Van Handel et al. (6) described a stimulation by exogenous 
cytochrome с on the rate of pyruvate oxidation by rat heart and skeletal 
muscle mitochondria isolated in an isotonic KCl medium. The authors suggested 
that previous studies in which cytochrome с was not included inttie assay 
medium have underestimated the respiratory capacity of the mitochondria. 
The experiments described in this chapter were designed to evaluate the 
suggestion that addition of cytochrome с compensates for cytochrome с lost 
during isolation. If this suggestion is true, a correlation must be present 
between the stimulation of pyruvate oxidation by exogenous cytochrome с and 
the cytochrome с content of the mitochondria after isolation. To vary the 
amount of cytochrome с skeletal muscle mitochondria were isolated in three 
different isolation media: isotonic sucrose-, isotonic KCl- and hypotonic 
sucrose. The effect of these different isolation media on morphology, specific 
activity of cytochrome oxidase, respiratory control index, P/0 ratio and cyto­
chrome content was studied as well as the effect of exogenous cytochrome с on 
the rate of pyruvate oxidation by these mitochondria. 
Possible relevance of the results for clinical investigations with human 
skeletal muscle mitochondria is discussed. 
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7.2. MATERIALS AND METHODS 
Isolation of skeletal musale mitochondria. Skeletal muscle mitochondria were 
isolated from the hind limb of male Wistar rats, weighing 150-200 g and fasted 
overnight. All operations were carried out between 0 and 4 . Mitochondria were 
isolated in one of the following media: 
a. isotonic sucrose. Muscle was freed from fat and connective tissue, cut into 
small pieces with scissors and suspended in a concentration of 1 g/10 ml in 
SETH medium, containing 250 mM sucrose, 2 mM EDTA, 10 mM Tris-HCl and 50 
U/ml héparine, final pH 7.4. This muscle mince was homogenized in a Potter-
Elvehjem homogenizer by hand. The homogenate was centrifuged twice for 10 
min at 600 xg to remove nuclei and cell debris. Mitochondria were isolated 
by centri fugati on for 10 min at 14000 xg. The mitochondrial pellet was 
rinsed and homogenized in SET medium, which is SETH medium from which 
héparine is omitted, and centrifuged again for 10 min at 14000 xg. 
b. isotonic KCl. Mitochondria were isolated as described above except that the 
sucrose in the SETH medium was replaced by 125 mM KCl. After the first 
14000 xg centrifugation step the mitochondrial pellet was resuspended in 
SET medium in which the mitochondria were also finally taken up. 
с hypotonic sucrose. Mitochondria were isolated as described above (a). After 
the first 14000 xg centrifugation step the mitochondrial pellet was rinsed 
and resuspended in SET medium which was diluted with distilled water to a 
final sucrose concentration of 50 mM. After centrifugation the mitochondria 
were finally taken up in SET medium. 
Cytochromes. Cytochromes were measured by difference spectrophotometry as 
described in the previous chapter. Reduction was achieved by adding 10 mM 
succinate plus 1 mM KCN to the sample cuvette. 
Oxygen consumption. Oxygen consumption was measured with 1 mM pyruvate and 1 
mM malate as substrates at 37 in the medium described by Max et al. (7), 
which is a simplified version of the medium described by Dow (8). Respiratory 
control index and P/0 ratio were calculated as described by Estabrook (9). 
14 14 
Pyruvate oxidation. The rate of CO- production from [1- С]pyruvate was 
measured in the presence of 1 mM malate as described in chapter 3. 
Electron microscopy. Mitochondrial pellets were fixed in 2 % glutaraldehyde, 
postfixed in 2 % osmium tetroxide, dehydrated with a graded series of ethanol 
and embedded in Epon 812. Ultrathin sections were double stained with uranyl-
acetate and leadcitrate and examined on a Philips EM-300 electron microscope. 
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Cytochrome oxidase. Cytochrome oxidase activity was determined in a medium 
containing 50 mM potassium phosphate, pH 7.4 and approximately 70 дМ reduced 
cytochrome c. The oxidation of cytochrome с was followed spectrophotometrically 
by monitoring the decrease in absorbance at 550 nm. Activity is expressed in 
units (μπιοί cytochrome с oxidized/mg protein min). The assay was performed at 
room temperature. 
Protein was determined according to Lowry et al. (10). 
7.3. RESULTS 
7.3.1. General eharacter-Lsties 
Electron micrographs of skeletal muscle mitochondria isolated in isotonic 
sucrose, show an intact mitochondrial membrane and a regular arrangement of 
cristae (Fig. 7.1). The use of isotonic KCl leads to mitochondrial prepara­
tions which are less pure and homogenous. Mitochondria isolated in hypotonic 
sucrose show swelling of the mitochondrial matrix but the mitochondrial 
membrane appears intact. The purity of this preparation is comparable to that 
observed with mitochondria isolated in isotonic sucrose. The effect of 
different isolation media on protein yield and specific activity of cytochrome 
oxidase is shown in Table 7.1. 
TABLE 7.1. 
EFFECT OF DIFFERENT ISOLATION MEDIA ON PROTEIN YIELD AND CYTOCHROME OXIDASE 
ACTIVITY 
Values shown are the means + S.D. of the number of experiments shown in the 
"arentheses. 
Isolation medium Protein Cytochrome с oxidase 
Isotonic sucrose 
Isotonic KCl 
Hypotonic sucrose 
(mg/g wet weight) 
0.78+0.21 (10) 
0.93 + 0.23 ( 5) 
0.88 + 0.05 ( 5) 
(u mol /min. mg protein) 
8.1 + 1.3 (6) 
5.2 + 0.7 (4) 
8.4 + 2.0 (4) 
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77 
•mr 
#•1 /-
5 &> ê 4. 
^^¿ш: ¿сШ Ш)і 
Fig. 7.1.В 
%ψ 
-<. ' 3 • 
Fig. 7.1.С 
Fig. 7.1. Electron micrographs of rat skeletal muscle mitochondria isolated in 
isotonic sucrose (A), isotonic KCl (В) and hypotonic sucrose (C). 
Magnification X 12,600. 
The amount of protein obtained per g wet weight is similar in each medium, but 
mitochondria isolated in isotonic KCl have a lower specific activity of cyto­
chrome oxidase. This indicates that the use of isotonic KCl leads to a mito­
chondrial preparation which is more contaminated with protein from non-mito-
chondrial origin. Furthermore, the total yield of cytochrome oxidase activity 
per g wet weight is lower in isotonic KCl isolated mitochondria which suggests 
a lower yield of mitochondria. 
7.3.2. Cytochrome content 
The use of isotonic KCl leads to a dramatic fall in the content of respiratory 
chain components of nearly 50 % as compared to the use of isotonic sucrose 
(Table 7.2). The ratio of the various cytochromes remains however fairly 
constant. Isolation of mitochondria in hypotonic sucrose has no effect on the 
levels of cytochrome aa, and b but leads to a preferential loss of cytochrome 
c+c, of about 20 %. 
TABLE 7.2. 
EFFECT OF DIFFERENT ISOLATION MEDIA ON CYTOCHROME CONTENT 
Values shown are the means + S.D. of the number of experiments given in the 
parentheses. 
Isolation medium 
Isotonic sucrose 
Isotonic KCl 
Hypotonic sucrose 
aa b c+c aa, b c+c. 
(relative amount) 
1.0 0.88 2.04 
1.0 0.90 1.93 
1.0 0.95 1.64 
(pmol/mg protein) 
(9) 417 + 29 366 + 21 849 + 82 
(5) 226 + 21 203 + 21 437 + 37 
(5) 405 + 14 386 + 29 665 + 43 
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7.3.3. Effect of exogenous cytochrome с on electron transport 
Mitochondria isolated in sucrose are superior to mitochondria isolated in iso­
tonic KCl with respect to respiratory control index and P/0 ratio (Table 7.3). 
TABLE 7.3. 
EFFECT OF CYTOCHROME С ON RESPIRATORY CONTROL INDEX AND P/0 RATIO 
Values shown are the means + S.D. of 8 (isotonic sucrose) or 5 (isotonic KCl, 
hypotonic sucrose) experiments. 
Where indicated cytochrome с was added in a final concentration of 20 μΜ. 
Isolation medium Cytochrome с RCI P/0 
Isotonic sucrose 
Isotonic KCl 
Hypotonic sucrose 
6.7 + 1.2 
6.6 + 1.0 
4.5 + 0.8 
4.6 + 0.7 
5.8 + 0.6 
6.7 + 0.6 
2.71 + 0.11 
2.70 + 0.11 
2.51 + 0.23 
2.51 + 0.23 
2.62 + 0.05 
2.60 + 0.10 
Exogenous cytochrome с has no effect on the respiratory control index of mito­
chondria isolated in isotonic sucrose or isotonic KCl. Addition of cytochrome 
с to mitochondria isolated in hypotonic sucrose increases the respiratory 
control index to the same value observed with mitochondria isolated in iso­
tonic sucrose. No effect is observed after addition of cytochrome с on the P/0 
ratio with any of the isolation media, which indicates that exogenous cyto­
chrome с does not interfere with the normal pathway of phosphorylation. Only 
under conditions where the pathway of electron transport via cytochrome oxida­
se is inhibited exogenous cytochrome с serves as terminal electron acceptor as 
appears from the following experiment (Fig. 7.2). Mitochondria were incubated 
with pyruvate and malate in the presence of cytochrome с and the reduction of 
cytochrome с was measured by monitoring the absorbance at 550 nm. No reduction 
of cytochrome с is observed unless a small amount of azide is added, which 
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causes partial inhibition of cytochrome oxidase (11). Subsequent addition of 
antimycin A in a concentration which completely blocks electron transport in 
the region between cytochrome b and cytochrome c, causes reoxidation of the 
previously reduced cytochrome с since under this condition transfer of elec­
trons from cytochrome с via cytochrome oxidase to oxygen is the only mode of 
ATP synthesis. 
0 05 
100 5 
I 1 
Fig. 7.2. Cytochrome с as terminal electron acceptor during pyruvate oxidation. 
Mitochondria (0.30 mg protein/ml) were incubated at room temperature in 
cuvettes in a final volume of 1 ml under the same conditions as employed for 
14 the assay of [1- Clpyruvate oxidation. The incubation medium was supplemented 
with 20 μΜ cytochrome с Reduction of cytochrome с was measured by monitoring 
the absorbance at 550 nm. Sodium azide (1 mM) and antimycin A (1 /ug) were 
added as indicated. 
7.3.4. Effect of exogenous eytoohrome a on pyruvate oxidation 
Table 7.4 shows the effect of addition of cytochrome с on the capacity of 
skeletal muscle mitochondria to oxidize pyruvate, measured by the production 
14 14 
of COp from [1- Clpyruvate. The pyruvate oxidation rate expressed on base 
of protein found with mitochondria isolated in isotonic sucrose is twice the 
activity found with mitochondria isolated in the other two media. However, 
when the oxidation rates are expressed as дтоі per unit cytochrome oxidase per 
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h or as nmol per pmol cytochrome aa, per h, the discrepancy between mitochon­
dria isolated in isotonic sucrose and isotonic KCl disappears, while the 
oxidation capacity of mitochondria isolated in hypotonic sucrose still remains 
half of that found with mitochondria isolated in isotonic sucrose. Exogenous 
cytochrome с has a small stimulatory effect on the rate of pyruvate oxidation 
when added to mitochondria isolated either in isotonic sucrose or KCl. The 
stimulatory effect on mitochondria isolated in hypotonic sucrose is consider­
able and results in an almost complete restoration of pyruvate oxidation 
capacity on base of cytochrome oxidase activity and on base of spectrally 
measured cytochrome aa, when compared to mitochondria isolated in isotonic 
sucrose or KCl. 
TABLE 7.4. 
EFFECT OF CYTOCHROME С ON THE RATE OF [1-14C]PYRUVATE OXIDATION 
Values shown are the means + S.D. of the number of experiments shown in the 
parentheses. 
Where indicated cytochrome с was added in a final concentration of 20 μΜ. 
cyt. ox.: cytochrome oxidase, cyt. aa.,: cytochrome aa,. 
Cyto-
Pyruvate oxidation rate 
Isolat ion medium
 rhrnmp r μπιοΐ/mg. дтоІ/итЧ nmol/pmol c n r o m e c
 protein.h. cyt. ox.h. cyt. aa 3 .h. 
Isotonic sucrose - 15.7 + 2.7 (10) 2.0 + 0.5 (6) 36.3 + 7.5 (IO1) 
+ 18.7 + 3.0 (10) 2.5 + 0.6 (6) 43.0 + 8.5 (10) 
Isotonic KCl - 7.4 + 1.4 ( 5) 1.9 + 0.7 (5) 33.2 + 7.6 ( 5) 
+ 9.9 + 1.8 ( 5) 2.4 + 0.8 (5) 42.0 + 9.9 ( 5) 
Hypotonic sucrose - 7.3 + 2.4 ( 5) 1.2 + 0.3 (5) 18.2 + 6.3 ( 5) 
+ 15.7 + 3.7 ( 5) 2.7 + 0.9 (5) 39.0 + 9.5 ( 5) 
The rate of pyruvate oxidation (expressed on cytochrome oxidase base) in the 
absence of exogenous cytochrome с versus the ratio between cytochrome c+c, and 
cytochrome aa, shows a normal shaped v/s curve. The stimulation of pyruvate 
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oxidation rate observed after addition of cytochrome с is inversely related to 
the amount of cytochrome с present in the mitochondria after isolation. By 
plotting the logarithm of the ratio of the pyruvate oxidation rate in the 
presence and absence of added cytochrome с versus the ratio between cytochrome 
c+c, and cytochrome aa, an almost linear relationship is obtained (Fig. 7.3) 
with a correlation coefficient of -0.87. 
cyl aa, 
Fig. 7.3. Correlation between endogenous cytochrome с (expressed as the ratio 
between cyt. c+c, and cyt. aa,) and the stimulation of pyruvate oxidation by 
exogenous cytochrome с 
V and V" represent the rate of pyruvate oxidation in the presence and absence 
of exogenous cytochrome c, respectively. 
7.4. DISCUSSION 
7.4.1. Sucrose versus KCl isolation medium 
From the specific activities of cytochrome oxidase it can be concluded that 
the use of isotonic KCl medium during isolation of skeletal muscle mitochon­
dria leads to mitochondrial suspensions which are more contaminated with protein 
from non-mitochondrial origin as compared with suspensions obtained after 
isolation in sucrose, which is in accordance with electron microscopic 
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findings. This explains the lower values found for the cytochrome content of 
isotonic KCl isolated mitochondria as compared with sucrose isolated mitochon­
dria, since these values are expressed on protein base (Table 7.2). The rate 
of pyruvate oxidation is lower in isotonic KCl isolated mitochondria as 
compared with isotonic sucrose isolated mitochondria (Table 7.4). However, 
when these values are compared on base of spectrally measured cytochrome aa, 
(reduced with succinate plus KCN) or on base of cytochrome oxidase activity, 
the difference almost disappears. This implies that by taking protein as a 
reference base misleading results may be obtained. This problem is not 
encountered by using cytochrome oxidase as a reference base, which is probably 
due to the exclusively mitochondrial localization of this enzyme (12). 
Although the rate of pyruvate oxidation, when correctly expressed, is almost 
the same with either isotonic sucrose or isotonic KCl isolated mitochondria, 
mitochondria isolated in isotonic sucrose are superior to mitochondria isola­
ted in isotonic KCl with respect to morphologic appearance (Fig. 7.1), speci­
fic activity of cytochrome oxidase (Table 7.1), respiratory control and P/0 
ratio (Table 7.3). 
7.4.2. Stimulation of pyruvate oxidation by aytoahrome a 
It has been known for a long time that cytochrome с stimulates substrate 
oxidations in heart (13) and skeletal muscle (14) mitochondria. In a recent 
report (6) a stimulation of pyruvate oxidation by exogenous cytochrome с was 
reported varying between 34 % and 66 % depending on the type of muscle. 
In our experiments, pyruvate oxidation by skeletal muscle mitochondria isola­
ted in isotonic sucrose or KCl shows a stimulation of about 20 % by exogenous 
cytochrome с It seems therefore that the isolation medium employed by Van 
Handel et al. (6), which contained 175 mM KCl and 2 mM EDTA, resulted in a 
greater loss of cytochrome с than the isotonic sucrose or KCl media we used. 
Isolation in hypotonic sucrose results in such a loss of cytochrome с from the 
mitochondria (Table 7.2) that stimulation of pyruvate oxidation by exogenous 
cytochrome с increases to 100 %. The correlation between the ratio of the 
pyruvate oxidation rates in the presence and absence of exogenous cytochrome с 
and the ratio between cytochrome c+c, and cytochrome aa 3 (Fig. 7.3) indicates 
that the stimulatory effect of cytochrome с is due to an increased substrate 
concentration of cytochrome oxidase. So, the oxidation capacity of skeletal 
muscle mitochondria is limited by the amount of cytochrome с present after 
isolation. No stimulation by exogenous cytochrome с will be obtained at a 
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ratio between cytochrome c+c, and aa, of 2.4 (Fig. 7.3). 
Although pyruvate oxidation is stimulated by addition of cytochrome c, no 
effect is seen on the P/0 ratio (Table 7.3) which is in agreement with the 
results found by other investigators (4, 13, 14). 
7.4.3. Impliaation for аігпгааі biochemistry 
Biochemical investigations with mitochondria isolated from muscle biopsy spe­
cimens are important for the diagnosis of mitochondrial myopathies (15, 16). 
The results reported in this chapter, although obtained with rat skeletal 
muscle mitochondria, have their consequences for workers in the clinical 
field. Especially the finding of discrepancies between pyruvate oxidation 
rates obtained with mitochondria isolated in different media which are merely 
related to the reference base used, stresses the importance of a good para­
meter for expressing measured activities. 
Protein appeared to be not suitable. Good reference bases seem to be cyto­
chrome oxidase activity or cytochrome 333, spectrophotometrically measured after 
reduction with succinate plus KCN. 
Some investigators use incubation media containing cytochrome с when measuring 
the oxidative capacity of skeletal muscle mitochondria (18, 19). The routine 
addition of cytochrome с to these media seems not advisable when measuring the 
oxidative capacity of patients skeletal muscle mitochondria for two reasons. 
First, deficiencies of cytochrome aa, and cytochrome b have been reported 
(chapter 2). Therefore, cytochrome с deficiencies might exist as well and can 
be masked by addition of cytochrome с to the incubation medium, unless cyto­
chromes are also measured separately. Secondly, cytochrome с can fullfill the 
role of terminal electron acceptor in case of inhibition of cytochrome oxidase 
(Fig. 7.2) and therefore mask a partial deficiency of cytochrome aa.,. 
7.5. SUMMARY 
Rat skeletal muscle mitochondria were isolated in three different isolation 
media: isotonic sucrose medium, isotonic KCl medium and hypotonic sucrose me­
dium. The use of isotonic KCl medium during isolation resulted in a mitochon­
drial preparation which was more contaminated with protein from non-mitochon-
drial origin than the use of sucrose media. This could be concluded from 
electron microscopy and the specific activity of cytochrome oxidase. Further­
more, respiratory control index values and cytochrome content were lower in 
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these mitochondria. The ratio between cytochrome c+c, and cytochrome aa, was 
similar after isolation in both isotonic media but was markedly lower after 
isolation in hypotonic sucrose. The highest rate of pyruvate oxidation was 
obtained with isotonic sucrose isolated mitochondria when this rate was ex­
pressed on protein base. When expressed on base of spectrally measured cyto­
chrome ааз reduced with succinate plus KCN, or on base of cytochrome oxidase 
activity, the rate of pyruvate oxidation was the same in isotonic sucrose- and 
isotonic KCl-isolated mitochondria. 
Exogenous cytochrome с stimulated pyruvate oxidation about 20 % in mitochon­
dria isolated in isotonic sucrose or KCl and about 100 % in mitochondria iso­
lated in hypotonic sucrose. In the latter case, oxidation rates in the pre­
sence of exogenous cytochrome с approached the values found with mitochondria 
isolated in isotonic sucrose. A clear inverse relationship between the content 
of endogenous cytochrome c+c, and the stimulatory effect of exogenous cyto­
chrome с is established. 
Implications of these results for clinical studies of oxidative capacity of 
skeletal muscle mitochondria are discussed. 
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CHAPTER 8 
THE USEFULNESS OF MUSCLE HOMOGENATES AND MITOCHONDRIA IN THE STUDY OF MITO-
CHONDRIAL MYOPATHIES 
8.1. INTRODUCTION 
In the previous chapters the methods for the measurement of pyruvate dehydro-
genase and citric acid cycle activity in intact muscle mitochondria as well as 
for the determination of the cytochrome content have been described. In this 
chapter the application of these methods for the study of mitochondrial myo-
pathies will be illustrated. 
Measurement of pyruvate dehydrogenase and citric acid cycle activity is not 
limited to mitochondrial suspensions but can also be performed in a muscle 
homogenate. The use of a homogenate has the advantage that less biopsy mate-
rial is needed. It is our experience that isolation of a sufficient amount of 
mitochondria is only possible from biopsy specimens weighing at least 0.7 g. 
Isolation of mitochondria is necessary for the determination of RCI and P/0 
ratio and for measurement of cytochromes. RCI and P/0 ratio cannot be measured 
in homogenates because of the high ATPase activity in the latter, resulting in 
increased state 4 oxidation rates. The concentration of mitochondrial pigments 
in a homogenate is too low to permit registration of a cytochrome spectrum. 
Based on these considerations the following sequence of determinations for the 
study of mitochondrial metabolism seems to be the most adequate one: a homo-
genate is prepared to measure pyruvate dehydrogenase and citric acid cycle 
activity and, when indicated, fatty acid metabolism. From the remaining part 
of the homogenate mitochondria can be isolated. If the yield of mitochondria 
is sufficient, RCI and P/0 ratio as well as a cytochrome spectrum are measu-
red. As an example of the application of these methods, the results obtained 
with a muscle biopsy specimen from a patient suspected to suffer from a mito-
chondrial myopathy will be presented. 
8.2. BIOCHEMICAL STUDIES ON SKELETAL MUSCLE MITOCHONDRIA FROM A PATIENT 
8.2.1. Case report 
The patient, G.R., a boy, was born in 1963. His history was uneventful until! 
the summer of 1977 when he experienced a period of extreme fatigue provoked by 
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prolonged exercise. This period lasted about 5 months during which he was un­
able to perform any exercise. In this period he was admitted to a local 
clinic. General examination revealed no abnormalities, except for an extreme 
fatigue. Laboratory investigations, including CPK, were normal. EMG and ECG 
showed no abnormalities. Myasthenia was excluded. During hospitalization the 
fatigue decreased and the patient was dismissed in an improved condition in 
december 1977. In 1978 an ischemic forearm test as well as an exercise test 
were performed. Both revealed no abnormalities. 
During hospitalization in 1977 a needle biopsy of the m.quadriceps was per­
formed for histopathological examination. An excess of intra-myofibrillar 
lipid and glycogen was found (Fig. 8.1). Mitochondrial morphology was ab­
normal. The usual parallel arrangement of the cristae was lost and the cristae 
seemed rounded up. These results indicated the presence of a myopathy and 
suggested that this myopathy might be from mitochondrial origin. A surgical 
biopsy of the m.quadriceps was performed in 1978. Although the fatigue had 
disappeared at that time, electron microscopical investigations gave results 
which were similar to those found in the first biopsy specimen. 
8.2.2. Results and discussion 
Activities of pyruvate dehydrogenase, citric acid cycle and cytochrome oxidase 
were measured in homogenate (Table 8.1). These activities were all within the 
normal range. Studies with isolated mitochondria showed normal values for RCI 
and P/0 ratio (Table 8.2) as well as a normal content of cytochromes (Table 
8.3). Part of the mitochondrial pellet was used for electron microscopical 
examination. No abnormalities were noticed (Fig. 8.2). Since all investiga­
tions gave results which were similar to those found in controls, a deficiency 
of one of the enzymes involved in pyruvate metabolism seems unlikely. 
8.3. GENERAL DISCUSSION 
Incubations according to the scheme presented in Table 8.1 can be performed 
with 50 μΐ of a 10 % /v homogenate for each assay. Since assays are per­
formed in duplicate a total volume of 600 μΐ of a 10 % homogenate is needed, 
which corresponds to 60 mg wet weight of muscle tissue. Since some loss of 
material occurs during preparation of the homogenate and also some material is 
needed for determination of protein content and cytochrome oxidase activity, 
about 100 mg of muscle tissue is sufficient for the determinations shown in 
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Fig. 8.1 
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Fig. 8.1. Electron micrograph of m.quadriceps from patient G.R. The tissue was 
fixed in glutaraldehyde and osmium tetraoxide, dehydrated in a graded series 
of alcohol and embedded in Epon 812. Ultrathin sections were stained with 
uranylacetate and leadcitrate. Note the abundance of lipid droplets inbetween 
the myofibrils and mitochondria. Also, the mitochondrial cristae show 
"rounding up". Magnification X 19.600. 
TABLE 8.1. 
1 4C0 2 PRODUCTION FROM LABELED SUBSTRATES AND CYTOCHROME OXIDASE ACTIVITY IN 
MUSCLE HOMOGENATE FROM PATIENT G.R. AND CONTROLS 
Incubation conditions were as described in the legends to Tables 3.3 and 4.1. 
The assays contained 0.15-0.30 mg homogenate protein. Values are expressed as 
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nmol COg/mg protein.h. 
Determination of cytochrome oxidase activity was performed at 37 as described 
in 7.E. Values are expressed as nmol/mg protein.min. 
Values of controls are the means + S.D. of the number of experiments given in 
the parentheses. 
G.R. controls 
3 2 4 + 8 8 (7) 
432 + 106 ( 7) 
376 + 132 ( 7) 
432 + 142 ( 7) 
263 + 9 3 (7) 
354 + 117 ( 5) 
88 + 33 (12) 
[l-Clpyruvate + malate 256 
[1- Clpyruvate + carnitine 286 
IU- Clmalate + pyruvate + malonate 400 
lU- Clmalate + acetylcarnitine + malonate 330 
[U- Clmalate + acetylcarnitine + arsenite 179 
[l-14C]2-oxoglutarate 431 
Cytochrome oxidase 109 
TABLE 8.2. 
OXYGEN CONSUMPTION, RCI AND P/O VALUES IN ISOLATED MUSCLE MITOCHONDRIA FROM 
PATIENT G.R. AND CONTROLS 
Oxygen consumption was measured with 1 mM pyruvate and 1 mM malate as sub-
strates at 37 according to Max et al. (2). The rate of oxygen consumption is 
given in ^ gat 0/mg protein.h. 
Control values are the means + S.D. of 4 experiments. 
G.R. 
Controls 
Oxygen 
state 3 
26.7 
23.0 + 4. 
consumption 
state 4 
3.6 
8 5.0 + 1.4 4, 
RCI 
7.4 
.6 + 1.0 
P/0 
2.9 
2.7 + 0.2 
TABLE 8.3. 
CYTOCHROME CONTENT OF ISOLATED MUSCLE MITOCHONDRIA FROM PATIENT G.R. AND 
CONTROLS 
Measurement of cytochromes was performed as described in 6.2. Reduction was 
achieved by addition of succinate plus KCN. 
Values of controls are the means + S.D. of 8 experiments. 
aa, b c+c, aa^ b c+c, 
(pmol/mg protein) (relative amount) 
G.R. 443 327 646 1.0 0.74 1.46 
Controls 374 + 117 290 + 71 648 + 187 1.0 0.78 1.73 
Fig. 8.2. Mitochondria isolated from a biopsy specimen (m.quadriceps) from 
patient G.R. For experimental details see 7.2. Magnification X 19.000. 
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Fig. 8.2 
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Table 8.1. These determinations can also be performed in suspensions of iso-
lated mitochondria but then an amount of 700 mg of muscle tissue is required 
for the isolation of mitochondria in normal conditions. Since the weight of a 
biopsy specimen is not always sufficient for isolation of mitochondria, we 
prefere to measure pyruvate dehydrogenase and citric acid cycle activity in 
muscle homogenates. 
In addition to the patient reported above, biochemical investigations concer-
ning mitochondrial metabolism were performed in a number of patients suffering 
from a myopathy which might be from mitochondrial origin. In none of these 
patients a defect in biochemical functioning of the mitochondria could be 
established. Therefore, the possibility must be considered that our methods 
are not always suitable to detect a defect in mitochondrial metabolism. 
The procedure for the isolation of skeletal muscle mitochondria differs only 
in details from that employed by other investigators. All procedures are based 
on the disruption of muscle tissue, either mechanically (1,2) or enzymatically 
(3) or both (4,5), followed by centrifugation at low speed to remove cell 
debris and nuclei. The resulting homogenate is centrifuged at high speed to 
sediment the mitochondria. Since a number of defects were found in mitochon-
dria isolated by such procedures (Chapter 2 ) , it is likely to assume that 
abnormal mitochondria can be isolated as well in this manner. Further evidence 
for the latter is provided by the fact that with our isolation procedure and 
method for determination of the cytochrome content we were able to establish a 
deficiency of both cytochrome aa, and cytochrome b in a patient, who is 
described in detail elsewhere (6). 
Ernster et al. (7) described an abnormal sedimentation behaviour of giant 
mitochondria isolated from a muscle biopsy specimen of a patient suffering 
from hypermetabolism. This might indicate inhomogeneity of the muscle mito-
chondrial population, at least under some pathological conditions. The bio-
chemical defect, loose-coupling, was however present in both normally and ab-
normally looking mitochondria. To obtain information about the homogeneity of 
a mitochondrial population tissue fractionation studies can be performed by 
differential centrifugation. This procedure is time consuming and requires 
large amounts of tissue. Alternatively, skeletal muscle mitochondria can be 
separated into subpopulations by centrifugation on a density gradient (8,9). 
This procedure is subject to the same disadvantages as the afore mentioned 
procedure and, in addition, the mitochondria are sometimes exposed to extreme-
ly hypertonic conditions (8). The information obtained from our measurements 
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will be the resultant of both normally and abnormally functioning mitochon­
dria, the former masking a possible defect present in the latter. However, 
there are no reasons to assume that this situation differs from the in vivo 
situation. 
The measurements of the rates of substrate oxidation by the mitochondria were 
performed in the presence of optimal substrate concentrations. These concen­
trations will probably be far above those present in vivo and are therefore 
most suitable to detect a deficiency of a certain enzyme, whereas defects 
resulting in a decreased substrate affinity may remain unnoticed under these 
conditions. Furthermore, as outlined by Galton et al. (10), metabolic diseases 
may not only be caused by deficiencies of enzymes but also by defects in 
regulation of enzyme activities. 
It is therefore our opinion that future biochemical research concerning 
skeletal muscle metabolism of patients should also be directed towards the 
development of methods which permit the study of mitochondrial metabolism 
under more physiological conditions. The system which seems most suited for 
this purpose is the isolated muscle cell, which has the advantage that the 
interrelationships between mitochondria and cytosol are preserved and that the 
mitochondria are in a more physiological environment. 
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SUMMARY 
A disturbance in functioning of skeletal muscle mitochondria may be one of the 
factors which can cause a myopathy. Such a myopathy is called a mitochondrial 
myopathy. The function of muscle mitochondria is to catalyze the oxidative 
catabolism of substrates coupled to the synthesis of energy. Pyruvate and 
fatty acids are the main substrates for skeletal muscle mitochondria, as out­
lined in Chapter 1. The experiments described in this thesis were performed to 
study the metabolism of mitochondria isolated from normal and diseased skele­
tal muscle. The investigations were limited to the oxidation of pyruvate and 
citric acid cycle intermediates. 
In Chapter 2 a literature survey is presented concerning the mitochondrial 
myopathies described up to now in which a biochemical defect could be esta­
blished. 
Measurement of the rate of pyruvate oxidation in isolated muscle mitochondria 
can be performed by determining the rate of C0 ? production from [1- C]pyru­
vate (Chapter 3). The stimulation of the rate of pyruvate oxidation by citric 
acid cycle intermediates and carnitine was studied and optimal conditions for 
measuring pyruvate oxidation in human muscle mitochondria were established. 
Experiments concerning citric acid cycle activity during oxidation of pyruvate 
plus malate are described in Chapter 4. Oxidation of pyruvate is accompanied 
by utilization of malate, which is due to accumulation of 2-oxoglutarate and 
succinate. Reconstitution of the malate-aspartate shuttle in the incubation 
medium eliminated 2-oxoglutarate accumulation and resulted in accumulation of 
glutamate. Due to the accumulation of cycle intermediates it is not possible 
to measure overall flux through the citric acid cycle. The activities of the 
first and the second segment of the cycle can be determined by measuring the 
rate of CO2 production from [U- Ci malate and from U- Cl 2-oxogl utarate, 
respectively. The activities of the enzymes of the last segment of the cycle 
can be tested by determining the stimulation of 11- Clpyruvate oxidation with 
succinate or fumarate. 
Oxidation of extra-mitochondrial NADH by isolated rat muscle mitochondria was 
studied by reconstitution of the malate-aspartate shuttle and the α-glycero­
phosphate shuttle (Chapter 5). The capacity for NADH oxidation by the re­
constituted malate-aspartate shuttle was about 50 t higher than by the «-
glycerophosphate shuttle. Considerable amounts of 2-oxoglutarate were with­
drawn from the malate-aspartate shuttle by the 2-oxoglutarate dehydrogenase 
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complex and were oxidized to succinate. An unknown interaction between the 
reconstituted shuttles was found which enables the malate-aspartate shuttle to 
perform NADH transport in the presence of an uncoupler and the reconstituted 
^-glycerophosphate shuttle. 
In Chapter б the measurement of cytochromes in mitochondria isolated from 
human muscle biopsy specimens is described. A reliable measurement of cyto­
chromes after reduction with dithionite is not possible, due to contamination 
of suspensions of human muscle mitochondria with hemoglobin or myoglobin. 
Therefore, reduction should be performed with succinate plus KCN. Measurement 
of cytochromes is also possible in mitochondria isolated from muscle biopsy 
specimens stored at -70°. However, storage of muscle tissue at -70° leads to a 
preferential loss of cytochrome с from the mitochondria. 
The effect of the use of different isolation media on some properties of rat 
muscle mitochondria is described in Chapter 7. Replacement of sucrose in the 
normal isolation medium by KCl resulted in mitochondrial preparations which 
were contaminated with protein from non-mitochondrial origin. Exposure of the 
mitochondria to a hypotonic shock during isolation resulted in a loss of cyto­
chrome с from the mitochondria. The rate of pyruvate oxidation in isolated rat 
muscle mitochondria can be stimulated by addition of cytochrome с to the incu­
bation medium. The increase in oxidation rate was dependent on the content of 
cytochrome с present in the mitochondria after isolation. 
In Chapter 8 the results obtained with a muscle biopsy specimen from a patient 
suspected to suffer from a mitochondrial myopathy are presented. This Chapter 
ends with a discussion on the usefulness of muscle homogenates and mitochon­
dria in the study of mitochondrial myopathies. 
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SAMENVATTING 
Een stoornis in het functioneren van skeletspier mitochondriën kan een van de 
factoren zijn welke een myopathie kunnen veroorzaken. Een dergelijke myopathie 
wordt een mitochondriale myopathie genoemd. De functie van spier mitochondriën 
is het katalyseren van het oxidatieve katabolisme van substraten gekoppeld aan 
de synthese van energie. Pyruvaat en vetzuren zijn de belangrijkste substraten 
voor skeletspier mitochondriën, zoals aangeduid in Hoofdstuk 1. De experimen-
ten welke in dit proefschrift zijn beschreven werden uitgevoerd om het meta-
bolisme van mitochondriën uit normale en pathologische skeletspier te bestu-
deren. Het onderzoek werd beperkt tot de oxidatie van pyruvaat en citroenzuur 
cyclus intermedi ai ren. 
In Hoofdstuk 2 wordt een literatuur overzicht gegeven van de tot nu toe be-
schreven mitochondriale myopathiën waarbij een biochemisch defect kon worden 
vastgesteld. 
Het meten van de snelheid van pyruvaat oxidatie in geïsoleerde spier mitochon-
14 driën kan uitgevoerd worden door de snelheid van de productie van CO, uit 
14 11- Clpyruvaat te bepalen (Hoofdstuk 3). De stimulering van de snelheid van 
de oxidatie van pyruvaat door citroenzuur cyclus intermediairen en carnitine 
werd bestudeerd en er werden optimale condities vastgesteld voor het meten van 
de pyruvaat oxidatie in humane spier mitochondriën. 
Experimenten betreffende de activiteit van de citroenzuur cyclus tijdens de 
oxidatie van pyruvaat plus malaat zijn beschreven in Hoofdstuk 4. De oxidatie 
van pyruvaat gaat gepaard met een verbruik van malaat, wat het gevolg is van 
de ophoping van 2-oxoglutaraat en succinaat. Reconstructie van de malaat-
aspartaat shuttle in het incubatie medium elimineerde de ophoping van 2-oxo-
glutaraat en resulteerde in ophoping van glutamaat. Vanwege de ophoping van 
cyclus intermediairen is het niet mogelijk om de overall flux door de cyclus 
te meten. De activiteiten van het eerste en tweede segment van de cyclus 
14 kunnen bepaald worden door de snelheid van C0? productie te meten uit 
г 14 ι ι 14 ι 
HJ- Cl malaat en 11- Cl 2-oxoglutaraat, respectievelijk. De activiteiten van 
de enzymen van het laatste segment kunnen bepaald worden door de stimulering 
van de oxidatie van 11- dpyruvaat door succinaat of fumaraat te bepalen. 
De oxidatie van extra-mitochondriaal NADH door geïsoleerde rattespier mito-
chondriën werd bestudeerd door de malaat-aspartaat shuttle en de a-glycero-
fosfaat shuttle te reconstrueren (Hoofdstuk 5). De capaciteit voor NADH oxida-
tie via de gereconstrueerde malaat-aspartaat shuttle was ongeveer 50 % groter 
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dan via de a-glycerofosfaat shuttle. Aanzienlijke hoeveelheden 2-oxoglutaraat 
werden aan de malaat-aspartaat shuttle onttrokken door het 2-oxoglutaraat 
dehydrogenase complex en werden geoxideerd tot succinaat. Er werd een on-
bekende interactie tussen de gereconstrueerde shuttles gevonden welke de 
malaat-aspartaat shuttle in staat stelt om NADH te transporteren in aanwezig-
heid van een ontkoppelaar en de gereconstrueerde a-glycerofosfaat shuttle. 
In Hoofdstuk 6 is de meting van cytochromen in mitochondriën geïsoleerd uit 
humane biopten beschreven. Een betrouwbare meting van de cytochromen na reduc-
tie met dithioniet is niet mogelijk ten gevolge van de contaminatie van sus-
pensies van humane skeletspier mitochondriën met hemoglobine of myoglobine. 
Daarom moet de reductie uitgevoerd worden met succinaat plus KCN. De meting 
van cytochromen is ook mogelijk in mitochondriën die geïsoleerd zijn uit bij 
-70 bewaarde biopten. Het bewaren van spierweefsel bij -70 leidt echter tot 
een preferentieel verlies van cytochroom с van de mitochondriën. 
Het effect van het gebruik van verschillende isolatie media op enige eigen-
schappen van rattespier mitochondriën wordt beschreven in Hoofdstuk 7. Ver-
vanging van de sucrose in het normale isolatie medium door KCl resulteerde in 
mitochondriale preparaten die verontreinigd waren met eiwit van niet mitochon-
driale origine. Het blootstellen van de mitochondriën aan een hypotone shock 
tijdens de isolatie resulteerde in een verlies van cytochroom с van de mito­
chondriën. De snelheid van de pyruvaat oxidatie in geïsoleerde rattespier 
mitochondriën kan gestimuleerd worden door toevoeging van cytochroom с aan het 
incubatie medium. De toename in oxidatie snelheid was afhankelijk van de hoe­
veelheid cytochroom с aanwezig in de mitochondriën na isolatie. 
In Hoofdstuk 8 worden de resultaten vermeld die verkregen werden met een 
spierbiopt van een patient die verdacht werd aan een mitochondriale myopathie 
te lijden. Dit Hoofdstuk besluit met een discussie over de bruikbaarheid van 
spier homogenaten en mitochondriën voor het bestuderen van mitochondriale 
myopathiën. 
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STELLINGEN 
I 
Voor de isolatie van skeletspier mitochondnèn verdient het gebruik van een isotoon 
sucrose medium de voorkeur boven het gebruik van een isotoon KCl medium. 
Dit proefschrift, hoofdstuk 7. 
II 
Het meten van een verschil spectrum van cytochromen na reductie met dithiomet kan 
aanleiding geven tot onbetrouwbare resultaten. 
Dit proefschrift, hoofdstuk 6. 
III 
De door Blass et al. beschreven deficiëntie van het 2-oxoglutaraat dehydrogenase 
complex in gesomficeerde fibroblasten van patiënten lijdende aan Friedreich's ata-
xie is moeilijk in overeenstemming te brengen met de normale waarden welke gevonden 
worden voor de oxidatiesnelheid van glutamaat in intacte fibroblasten. 
Blass, J.P., Kark, R.A.P. and Menon, N.K. (1976) New Engl. J. Med. 295, 62 - 67. 
Kark, R.A.P., Blass, J.P. and Engel, W.K. (1974) Neurology 24, 964 - 971. 
IV 
Bij het evalueren van resultaten welke verkregen zijn uit onderzoek van gekweekte 
adulte skeletspiercellen dient men zich rekenschap te geven van het feit dat in 
deze gekweekte cellen ook foetale kenmerken tot expressie komen. 
JiMauro, S., Arnold, S., Miranda, A. and Rowland, L.P. (1978) Ann. 
Neurol. 3, 60 -66. 
Pardndge, W.M., Oavidson, M.B. and Gasane!lo-Ertl, D. (1978) J. Cell. 
Physiol. 96, 309 - 318. 
V 
Het "haastige spoed is zelden goed" is ook van toepassing op de pogingen om de duur 
van de analyse van aminozuren in fysiologische vloeistoffen zo kort mogelijk te 
maken. 
VI 
Ue stijging van de carnitine concentratie in de lever tijdens vasten kan verklaard 
worden door een afname in het gewicht van de lever bij een gelijkblijvende totale 
hoeveelheid carnitine. 
Brass, E.P. and Hoppel, C.L.(1978) J. Biol. Chem. 253, 2688 - 2693. 
VII 
Het beoordelen van aanvragen voor subsidie voor wetenschappelijk onderzoek dient 
m e t te geschieden door personen die zich in een competitie positie ten opzichte 
van de aanvrager bevinden. 
VIII 
Het verdient aanbeveling om tijdschriften in te binden op een manier die de moge-
lijkheid openlaat om later nog leesbare fotokopieën te maken. 
IX 
ùe verplichting tot het toevoegen van stellingen die geen betrekking hebben op het 
onderwerp van het proefschrift dient afgeschaft te worden. 
Nijmegen, 22 december 1978. H. Bookelman. 


